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ABSTRACT 
JENNIFER BETH GRIFFIN: The Effects of Malaria in Pregnancy on Utero- and 
Fetoplacental Blood Flow and Fetal Growth: a longitudinal Doppler ultrasound study 
from Kinshasa, Democratic Republic of Congo 
(Under the direction of Steven R. Meshnick) 
 
Malaria during pregnancy is thought to affect both uterine and umbilical artery blood 
flow, leading to decreased oxygen and nutrient exchange between the mother and fetus, 
and ultimately to intrauterine growth restriction. 
We examined the effect of concurrent malaria on changes in uterine artery and umbilical 
artery resistance indices over gestational age. We used data from 177 pregnant women 
enrolled in a longitudinal Doppler ultrasound study. Women with high uterine artery and 
umbilical artery resistance had neonates that weighed less and were smaller. Compared 
to multigravidae with no malaria, primigravidae with concurrent malaria had an 11-13% 
increase in uterine artery resistance. Compared to women with no concurrent malaria 
and a male fetus, concurrent malaria caused an acute 10-14% increase in umbilical 
artery resistance among women female fetus, while women with a male fetus and 
concurrent malaria had a 2-3% increase in umbilical artery resistance. 
We also examined the effect of early pregnancy malaria parasitemia (≤20 weeks’ 
gestation) on subsequent changes in uteroplacental blood flow and fetal growth among a 
subset of 128 women with early pregnancy malaria exposure data. Early pregnancy 
malaria infection affected placentation, reflected by changes in uterine artery blood flow. 
Among nourished women, early pregnancy malaria decreased uterine artery resistance 
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(-0.036; 95% CI: -0.065, -0.0058), but among undernourished women, early pregnancy 
malaria increased uterine artery resistance (+0.022; 95% CI: -0.031, 0.074). Among 
primigravidae, early pregnancy malaria decreased umbilical artery resistance, reflecting 
adaptive villous angiogenesis with early pregnancy malaria. Primigravidae with early 
pregnancy malaria had 3.6 times the risk of subsequent IUGR (95% CI: 2.1, 6.2) 
compared to multigravidae with no early pregnancy malaria. 
Our findings point to both the acute effects of concurrent parasitemia and the effects of 
early pregnancy malaria on placental development. The acute effects of malaria on 
placental blood flow indicate the need for management and control strategies during 
pregnancy. Early pregnancy malaria infection leads to changes in placentation, villous 
angiogenesis, and intrauterine growth restriction. Our findings support the initiation of 
malaria prevention and control efforts earlier in pregnancy. 
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CHAPTER 1 - SPECIFIC AIMS 
Plasmodium (P.) falciparum malaria in pregnancy is associated with adverse 
pregnancy outcomes for the mother and fetus, including maternal anemia and low birth 
weight (LBW) (<2500 gms) due to preterm and intrauterine growth restriction (IUGR) 
(Brabin and Rogerson 2001; Steketee, Nahlen et al. 2001). LBW infants have an 
increased risk of acute morbidity and mortality, as well as having an increased risk of 
chronic disease later in life (Williams, Creasy et al. 1982; Ashworth 1998; Kramer 2003). 
While there are likely multiple mechanisms by which malaria in pregnancy leads to LBW 
(Rogerson, Hviid et al. 2007), one is thought to be the reduction of utero- and 
fetoplacental blood flow (Arbeille, Carles et al. 1998; Dorman, Shulman et al. 2002). 
The placenta develops with the primary function of providing oxygen and 
nutrients to the growing fetus. The uterine artery brings blood enriched with oxygen and 
nutrients from the mother to the placenta, while the umbilical artery brings deoxygenated 
blood with waste products from the fetus to the placenta. In the placenta, oxygen and 
nutrient exchange occurs. Pathophysiological events that alter the placental environment 
can decrease blood flow in the uterine or umbilical arteries, leading to a reduced 
capacity to transport oxygen and nutrients and, ultimately, to restricted fetal growth. 
Malaria in pregnancy has previously been found to be associated with abnormal utero- 
and fetoplacental circulation in the late second and early third trimesters (Arbeille, Carles 
et al. 1998; Dorman, Shulman et al. 2002). 
Longitudinal ultrasound studies can be used to investigate the effects of malaria 
infection on utero- and fetoplacental circulation and fetal growth throughout pregnancy. 
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Doppler ultrasound of the uterine and umbilical arteries directly evaluates blood 
perfusion of the maternal and fetal compartments of the placental circulation, 
respectively (Abramowicz and Sheiner 2008). In addition, fetal biometry measurements 
can be used to estimate fetal weight and to identify IUGR fetuses by comparing 
estimated fetal weights to population growth charts. 
The primary objective of this dissertation is to longitudinally examine the effect of 
malaria on changes in placental blood flow and on intrauterine growth restriction. 
Several definitions of malaria parasitemia will be explored in the analyses, as these 
definitions may help elucidate pathological processes. In our analyses, will use 
quantitative real-time polymerase chain reaction (qPCR) detected P. falciparum 
parasitemia; using qPCR we have shown many misclassifications of malaria diagnosis 
by peripheral blood microscopy in this cohort (Taylor, Juliano et al.). 
The data are from Project ECHO, a prospective, longitudinal study of 182 
pregnant women conducted at Binza Maternity Hospital in Kinshasa, Democratic 
Republic of Congo between May 2005 and May 2006 (Landis, Lokomba et al. 2009). 
Women participated in monthly follow-up visits during which malaria, maternal 
anthropometrics, fetal biometrics, and Doppler ultrasound data were measured. All 
enrolled women received iron supplementation and intermittent preventive treatment 
(IPTp) for malaria at two time points as a part of routine antenatal care. Women received 
additional treatments for malaria at monthly visits in which women were found to be 
peripheral blood smear-positive for malaria infection.  
Project ECHO data uniquely allow us to examine the relationship between 
malaria, blood flow and fetal size for several reasons: 1) accurate pregnancy dating; 2) 
longitudinal measures of utero- and fetoplacental blood flow and fetal biometrics; and 3) 
concurrent serial measures of malaria parasitemia, based on qPCR. 
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Specific Aim 1 
To examine the effect of malaria parasitemia on changes in uterine artery (UtA) and 
umbilical artery (UA) resistance indices (RI) over time.  
Justification 
Decreased uteroplacental blood flow is a hypothesized mechanism by which 
malaria in pregnancy is thought to lead to LBW. Previous studies have shown acute 
effects of malaria during the late second and early third trimesters on uterine artery 
resistance among primigravidae and on umbilical artery resistance in all gravidae. 
However, the effect of malaria on uteroplacental blood flow over the course of pregnancy 
has not been examined in a longitudinal setting. We will use linear mixed effect models 
to estimate the effect of malaria on UtA RI and UA RI from approximately 18 weeks’ 
gestation to term. The main binary, time-dependent malaria exposure will be defined as 
whether a woman was positive for P. falciparum malaria by qPCR of peripheral blood at 
the visit in which the ultrasound measure of uteroplacental blood flow were taken. We 
will determine if the effect of malaria varies over gestational age. We will also examine 
effect measure modification by gravidity, fetal sex, and maternal nutritional status. 
Hypotheses to be tested 
1. Is the effect of malaria on UtA RI and UA RI different than the null? 
2. Does the effect of malaria on UtA RI and UA RI change over time? 
3. Is the effect of malaria on UtA RI and UA RI modified by gravidity, fetal sex, 
or maternal nutritional status? 
Specific Aim 2 
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A. Estimate the effect of malaria in early pregnancy on subsequent uterine 
artery and umbilical artery resistance indices over time 
B. Estimate the effect of malaria in early pregnancy on subsequent intrauterine 
growth restriction 
Justification 
It has been hypothesized that malaria in early pregnancy disrupts the process of 
placentation, particularly extravillous trophoblast invasion and transformation of the 
maternal spiral arteries (as in preeclampsia). Should an early pregnancy malaria insult 
disrupt placentation, it could lead to problems in later pregnancy, including intrauterine 
growth restriction. To date, the effect of early pregnancy malaria on subsequent utero- 
and fetoplacental blood flow (providing information on placentation and villous 
angiogenesis, respectively) and fetal growth over the course of pregnancy has not been 
investigated. We will use linear mixed effect models to estimate the effect of malaria on 
the continuous, time-dependent outcomes, including uterine artery resistance index and 
umbilical artery resistance index, from 21 weeks’ gestation to term. We will use log-
binomial general estimating equation regression models with an exchangeable working 
correlation matrix to estimate the effect of early pregnancy malaria on the time-varying, 
binary outcome intrauterine growth restriction from 21 weeks’ gestation to term. The 
main binary, time-independent malaria exposure will be defined as whether a woman 
was positive for P. falciparum malaria by qPCR of peripheral blood prior to 21 weeks’ 
gestation. We will determine if the effect of early pregnancy malaria varies over 
gestational age. We will also examine effect measure modification by gravidity, fetal sex, 
and maternal nutritional status. 
Hypotheses to be tested 
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1. Is the effect of early pregnancy malaria on subsequent UtA RI, UA RI or 
IUGR different than the null? 
2. Does the effect of early pregnancy malaria on UtA RI, UA RI or IUGR change 
over time? 
3. Is the effect of early pregnancy malaria on UtA RI, UA RI or IUGR modified 
by gravidity, fetal sex, or maternal nutritional status?
CHAPTER 2 – BACKGROUND AND SIGNIFICANCE 
Epidemiology of malaria in pregnancy 
Pregnant women are more vulnerable to malaria infection than non-pregnant 
adults, with more frequent parasitemia, higher parasite densities, and more severe 
disease (Brabin 1983; McGregor 1984; Brabin and Rogerson 2001). In sub-Saharan 
Africa, there are 30 million pregnancies occurring annually in areas with Plasmodium 
falciparum transmission, with the vast majority (98.7%) living in areas of stable 
transmission (WHO 2003; Dellicour, Tatem et al. 2010). Approximately one-quarter of 
pregnant women in African malaria-endemic settings have evidence of either peripheral 
or placental parasitemia at delivery (McGregor, Wilson et al. 1983; Bulmer, Rasheed et 
al. 1993; Steketee, Nahlen et al. 2001; Guyatt and Snow 2004). The peak prevalence of 
malaria infection in pregnancy occurs from approximately 13 to 20 weeks’ gestation and 
decreases throughout pregnancy (Brabin 1983). 
The risk of malaria in pregnancy varies based on factors such as gravidity, 
maternal age, and the existence of co-morbidities, particularly human immunodeficiency 
virus (HIV) infection. Malaria in pregnancy is more frequent and severe in first and 
second pregnancies, with approximately twice the prevalence of malaria among 
primigravidae compared to multigravidae (Brabin 1983; McGregor, Wilson et al. 1983; 
Brabin and Rogerson 2001). Age is an independent risk factor for malaria in pregnancy, 
with younger pregnant women being particularly susceptible to malaria, regardless of 
gravidity (Rogerson, Van den Broek et al. 2000; Walker-Abbey, Djokam et al. 2005). 
HIV-infection has been shown to shift the burden of malaria from primigravidae to all 
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gravidae, causing more frequent peripheral and placental malaria, higher parasite 
densities, more severe illness, and worse pregnancy outcomes (Steketee, Nahlen et al. 
2001; ter Kuile, Parise et al. 2004). 
The epidemiology of malaria in pregnancy is also highly dependent on the 
intensity of transmission. In stable transmission settings, adults have high levels of 
naturally acquired immunity and most malaria infections are asymptomatic. In these 
areas, malaria in pregnancy primarily causes asymptomatic infection; however, malaria 
in pregnancy may lead to maternal anemia and placental parasitemia, both of which 
contribute to low birth weight (Nosten, Rogerson et al. 2004). In low transmission 
settings, adults have no significant levels of acquired immunity and typically have 
malarial disease when parasitemic. In these areas, malaria in pregnancy may cause 
episodes of severe or cerebral malaria, which can lead to stillbirths, spontaneous 
abortion, or premature delivery, as well as maternal mortality (Nosten, Rogerson et al. 
2004). 
Malaria in pregnancy is known to have significant direct health effects on the 
mother, the fetus and the neonate including: severe maternal anemia and related 
maternal mortality; low birth weight from both preterm delivery and intrauterine growth 
restriction; and, infant mortality (Steketee, Nahlen et al. 2001). Malaria in pregnancy is 
estimated to contribute 2-15% of maternal anemia in endemic settings (Steketee, Nahlen 
et al. 2001), which may lead to severe maternal anemia. Severe maternal anemia is a 
known risk factor for maternal mortality (Brabin, Hakimi et al. 2001), and is an 
independent cause of low birth weight (Rasmussen 2001; Levy, Fraser et al. 2005). In 
endemic areas, P. falciparum malaria during pregnancy has been estimated to 
contribute approximately 13 - 70% of low birth weight due to intrauterine growth 
restriction and 8 - 36% of low birth weight due to preterm (Steketee, Nahlen et al. 2001). 
Considering that infant mortality varies across malaria-endemic settings (from 50-160 
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deaths per 1,000 live births), it has been estimated that 75,000 to 200,000 infant deaths 
are attributable globally to malaria in pregnancy each year (Steketee, Nahlen et al. 
2001).  
Epidemiology of intrauterine growth restriction 
Low birth weight (<2500 g or 5 lb, 8 oz) is caused by both preterm delivery (<37 
weeks’ gestation) (PTD) and IUGR. While LBW remains a frequently used designation of 
fetal growth, particularly in the developing world, Lubchenco first demonstrated that 
small fetuses relative to those of the same gestational age (i.e. “small for gestational 
age” or “SGA”) best identified small neonates at risk of neonatal morbidity and mortality 
(Lubchenco, Hansman et al. 1963). SGA fetuses include both constitutionally small 
fetuses, which are meeting their genetic growth potential, and IUGR fetuses, which are 
small due to underlying pathology and have an increased risk of morbidity and mortality 
(Ott 1997; Baschat and Weiner 2000). SGA and IUGR are frequently used 
interchangeably in the medical literature, leading to confusion in terminology. 
In developing countries, where the prevalence of LBW is very high, most LBW is 
due to IUGR rather than preterm (Villar and Belizan 1982; de Onis, Blossner et al. 1998; 
Steketee, Nahlen et al. 2001; Kramer 2003). A recent review of LBW estimated that 24% 
of all neonates in developing countries were IUGR, or approximately 30 million infants 
per year (de Onis, Blossner et al. 1998). One in five infants in sub-Saharan Africa is 
estimated to suffer from IUGR (de Onis, Blossner et al. 1998; Kramer 2003). In malaria-
endemic regions, maternal undernutrition (characterized by low gestational weight gain, 
low pre-pregnancy BMI, and short stature) and malaria are the primary risk factors for 
IUGR (Kramer 2003). Other important determinants of IUGR in the developing world 
include: smoking; primiparity; pregnancy-induced hypertension; congenital anomalies; 
and, other genetic factors (Kramer 2003).  
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Intrauterine growth restricted fetuses have an increased risk of mortality, acute 
morbidity and an increased risk of chronic disease later in life (Williams, Creasy et al. 
1982; Ashworth 1998; Kramer 2003). Generally, the risk of morbidity and mortality 
increases at lower weights. IUGR fetuses have an increased risk of stillbirth and IUGR 
infants have an increased risk of neonatal death (Kramer 2003). Acute morbidity 
includes hypoglycemia, hypocalcemia and polycythemia; chronic effects include small, 
permanent deficits in growth and neurocognitive development (Kramer 2003). 
Additionally, recent research indicates that several important chronic diseases of middle-
age including coronary heart disease, hypertension and type-2 diabetes may originate in 
impaired intrauterine growth and development (Godfrey and Barker 2000; Barker 2006). 
Intrauterine growth restriction is sometimes sub-classified as symmetrical or 
asymmetrical, with approximately 70% of IUGR fetuses presenting with asymmetrical 
growth (Pollack and Divon 1992; Regnault, Galan et al. 2002). In symmetrical IUGR, 
there is an overall reduction in fetal size, including head circumference and skeletal size; 
in asymmetrical IUGR, the skeletal dimensions and head circumference are spared, 
while the abdominal circumference is decreased due to decreased liver size and a 
scarcity of fat (Resnik 2002). However the utility of these sub-categories is questionable 
as the association is confounded by the severity of the growth restriction, with 
asymmetric IUGR infants tending to be more severely growth restricted (Kramer 2003) 
An overview: the placenta and fetal growth 
From early pregnancy through the second trimester, there are two waves of 
trophoblast invasion, in which the maternal spiral arterioles are transformed into larger, 
less rigid vascular channels that are maximally dilated (Guzman 2005; Abramowicz and 
Sheiner 2008). Concurrently, there is extensive angiogenesis in the placental tissue and 
development of tertiary villi in the placenta, leading to a sharp increase in umbilical blood 
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flow. Both the transformation of the uterine vasculature and placental angiogenesis are 
critical for the conversion of the previously high resistance system into a low resistance 
system that ensures adequate blood flow to the placenta and fetus during pregnancy 
(Guzman 2005; Abramowicz and Sheiner 2008; Abuhamad 2008).  
Normal fetal growth is primarily determined by nutrient transport across the 
placenta from the maternal to the fetal circulation. In the placenta, the maternal and fetal 
circulations come into close proximity to one another for respiratory gas and nutrient 
exchange, but remain separated by the villous trophoblast (Gude, Roberts et al. 2004). 
Maternal uterine arteries feed the spiral arteries which supply maternal blood to the 
intervillous spaces of the placenta via pulsatile blood flow where it circulates around the 
chorionic villi. The chorionic villi are supplied with deoxygenated fetal blood by terminal 
branches of the umbilical arteries. Gas exchange occurs in the villi and the blood is 
returned to the fetal circulation by branches of the umbilical vein (Gude, Roberts et al. 
2004; Abramowicz and Sheiner 2008). After gas exchange, the deoxygenated maternal 
blood is drained from the placenta by the endometrial veins (Gude, Roberts et al. 2004). 
In addition to respiratory gas and nutrient exchange, the placenta releases metabolic 
products; protects the fetus from infection; and, releases hormones affecting pregnancy, 
metabolism, and fetal growth (Gude, Roberts et al. 2004).  
The placenta develops with the primary function of providing oxygen and 
nutrients to the growing fetus; however, pathophysiological events may impede this 
function. The capacity of the placenta to meet the nutritional needs of the fetus is 
dependent on several factors including adequate uterine and umbilical artery blood 
flows; the concentration gradient between maternal and fetal blood; and the expression 
and activity of transporters located both on the microvillous and the basal plasma 
membrane of the syncytiotrophoblast (Jones, Powell et al. 2007). Pathophysiological 
events that impede either the transformation of the uterine vasculature or placental 
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angiogenesis may lead to increased impedance in the uterine and/or umbilical arteries, a 
reduced capacity to transport oxygen and nutrients (i.e. placental insufficiency) and, 
ultimately, restricted fetal growth (Abramowicz and Sheiner 2008). 
Doppler ultrasonography of blood flow velocity waveforms 
Doppler ultrasound is a powerful clinical tool that to assess hemodynamic 
information and placental performance in pregnancy via blood flow velocity waveforms 
(Maulik 2005; Abramowicz and Sheiner 2008). As the velocity of flow in a particular 
vascular bed is inversely proportional to downstream impedance to flow, evaluation of 
the change in maximal Doppler shifts over time provides information on the downstream 
impedance to flow (Guzman 2005; Abuhamad 2008). When sampled from the arterial 
circulation, a flow velocity waveform depicts one cardiac cycle. The left limit of the wave 
corresponds with the onset of systole, the zenith of the wave with peak systole, and the 
right limit with end diastole (Maulik 2005). The frequency shift is highest during systole, 
when the blood flow is at its fastest, and lowest during end-diastole, when the blood flow 
is at its slowest in the peripheral circulation (Abuhamad 2008). Flow velocity waveforms 
with high diastolic flow are seen when downstream resistance is low, and those with low 
(or reverse) diastolic flow are found when downstream resistance is high (Guzman 
2005). 
Techniques for analyzing the flow velocity waveform involve deriving Doppler 
indices or ratios from various combinations of the peak systolic, end-diastolic, and 
temporal mean values of the maximum frequency shift envelope from a single cardiac 
cycle (Maulik 2005). There are three semi-quantitative techniques for the analysis of 
Doppler waveforms that are widely used in obstetric practice, including the resistance 
index (RI) of Pourcelot [(S-D)/S]; the pulsatility index (PI) [(S-D)/ the temporal average 
frequency over one cycle]; and the SD ratio (Figure 2.1). Some have argued that no 
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particular index has proven to offer a clinical advantage over others (Guzman 2005), 
while others have argued in favor of a particular index (Maulik 2005). In one prospective 
study, the RI was found to have the best and the PI the worst discriminatory 
performance for adverse pregnancy outcomes (Maulik 2005). 
Doppler assessment of the uterine and umbilical arteries 
The left and right uterine arteries are the main blood supply to the uterus via the 
radial, basal and spiral arteries (Abramowicz and Sheiner 2008). Although the uterine 
arteries do not directly perfuse the placenta, several conditions ultimately affecting the 
placenta and the fetus may be predicted through Doppler analysis of the uterine arteries 
(Abramowicz and Sheiner 2008). The assessment of uterine blood flow is considered the 
best clinical method to evaluate the uterine circulation and the maternal compartment of 
the placental circulation (Abramowicz and Sheiner 2008; Abuhamad 2008).  
In early pregnancy, normal uterine artery waveforms are characterized by a high 
systolic component and low end-diastolic pattern, with a prominent early diastolic notch 
(Coppens, Loquet et al. 1996; Abramowicz and Sheiner 2008). Following extravillous 
trophoblast conversion of the spiral arteries around 15-17 weeks’ gestation, the 
uteroplacental circulation is converted to a high-flow, low resistance system. As a result, 
Doppler indices decrease and the early diastolic notch disappears. While the early 
diastolic notch can sometimes persist until 20-26 weeks’ gestational age in a normal 
pregnancy, persistent notching after 17-22 weeks’ gestation is thought to be indicative of 
abnormal uterine artery circulation (Guzman 2005; Abuhamad 2008). An early diastolic 
notch that persists after 17 weeks’ gestation is associated with an increased risk of 
IUGR and hypertensive disorders of pregnancy (Abramowicz and Sheiner 2008). The 
various waveform indices of the uterine artery show a progressive decrease until 
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approximately 26 weeks’ gestational age, after which there are few changes with 
gestational age (Guzman 2005; Abramowicz and Sheiner 2008). 
Defective trophoblast invasion and failure of physiologic transformation of the 
spiral arteries result in persistent notching and/or elevation of the uterine artery Doppler 
index (Miller, Turan et al. 2008). Several criteria define an abnormal uterine artery 
waveform: 1) elevated Doppler indices; 2) presence of a diastolic notch after 22 weeks; 
and, 3) a lack of difference in indices obtained from the uterine arteries on the placental 
and non-placental side (Abramowicz and Sheiner 2008; Miller, Turan et al. 2008). 
Increased uterine artery resistance and notching after 20 weeks’ gestation is associated 
with preeclampsia, IUGR and adverse pregnancy outcomes (Trudinger, Giles et al. 
1985). 
The assessment of umbilical blood flow is the best clinical method to evaluate 
blood perfusion of the fetal compartment of the placental circulation (Baschat 2005; 
Abramowicz and Sheiner 2008). The typical flow waveform in the umbilical cord consists 
of a saw-tooth arterial tracing above the baseline (Abramowicz and Sheiner 2008). 
Normal umbilical artery flow waveforms are characterized by an absent end-diastolic 
component prior to 12 weeks’ gestation. Diastolic velocities emerge between 12 and 14 
weeks’ gestation, with a progressive increase in end-diastolic flow seen with advancing 
gestation due to the proliferation of tertiary stem villi and small arterial channels that 
occurs with placental maturation (Coppens, Loquet et al. 1996; Abramowicz and Sheiner 
2008; Abuhamad 2008). This increase in end-diastolic flow is reflected in a decrease in 
the resistance indices with advancing gestational age. In humans, umbilical blood flow 
increases in direct proportion to the increase in fetal body weight (Abramowicz and 
Sheiner 2008). 
Diseases that reduce the proliferation of tertiary stem villi and small arterial 
channels in the placenta result in increased vascular resistance, which is reflected by a 
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decrease in the end-diastolic flow of the umbilical artery (Abramowicz and Sheiner 
2008). Umbilical artery Doppler indices become elevated when 30% of villous 
vasculature is abnormal (Miller, Turan et al. 2008). With even greater vascular 
resistance, absent or revered end-diastolic velocity may be seen (Baschat, Gembruch et 
al. 2001; Abuhamad 2008). The presence of absent or revered end-diastolic velocity in 
the umbilical arteries represents advanced fetal compromise, associated with greater 
than 70% of placental arterial obliteration (Abuhamad 2008). However, placental 
vascular dysfunction with fetal hypoxemia may exist in the absence of any Doppler 
findings (Miller, Turan et al. 2008). Doppler changes precede clinical manifestations for 
adverse changes in the fetus (Baschat, Gembruch et al. 2001; Miller, Turan et al. 2008; 
Turan, Turan et al. 2008). Increased umbilical artery resistance is associated with fetal 
distress and IUGR (Giles, Trudinger et al. 1985; Trudinger, Giles et al. 1985). 
Doppler ultrasonography for identification of the IUGR fetus 
The ability to accurately identify a small fetus is dependent on three things, 
namely: 1) estimated gestational age; 2) estimated fetal weight; and, 3) a weight 
percentile calculated from an appropriate fetal growth curve. Standardized Doppler fetal 
biometric parameters are used to estimate gestational age and fetal weight, including the 
biparietal diameter (BPD), the head circumference (HC), the abdominal circumference 
(AC) and the femur length (FL). 
Estimating gestational age 
There are two primary methods to estimating in utero gestational age (GA): 1) 
the first day of the last menstrual period (LMP); and, 2) ultrasound dating via fetal 
biometry parameters. While straightforward and inexpensive, the validity of LMP is 
decreased by the uncertain recall of LMP dates; digit preference; and, biologic variation 
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in the timing of ovulation, the timing of fertilization, and non-menstrual bleeding (Lynch 
and Zhang 2007). Ultrasound dating has been shown to provide a superior estimate of 
gestational age (Savitz and Terry 2002), even when LMP dates are considered certain 
(Mongelli, Wilcox et al. 1996). In the ultrasound estimation of gestational age, multiple 
fetal biometric parameters are measured and compared to a fetal size nomogram that 
has been correlated with gestational age. The main limitation of this method is that 
estimates of gestational age will be biased if the fetus is either large (upward bias) or 
small (downward bias). However, dating formulae that rely on multiple fetal parameters 
are thought to reduce the magnitude of this bias; nearly all estimates of gestational age 
from published formulae fall within one-week of the actual gestational age (Chervenak, 
Skupski et al. 1998). 
Doppler assessment of estimated fetal weight 
There are numerous regression formulae utilizing Doppler-assessed fetal 
biometric parameters for the in utero estimation of fetal weight (EFW), reviewed in 
(Kurmanavicius, Burkhardt et al. 2004; Dudley 2005; Anderson, Jolley et al. 2007; 
Scioscia, Vimercati et al. 2008). The abdominal circumference alone is a good marker 
for estimating fetal weight, with the accuracy of the measurement increasing with the 
addition of BPD, HC, and FL parameters (Hadlock, Harrist et al. 1985; Dudley 2005; 
Scioscia, Vimercati et al. 2008). The addition of parameters beyond AD, BPD, HC and 
FL does not improve accuracy in the estimation of fetal weight due to increased 
measurement error. 
While sonographically estimated fetal weight is commonly used in clinical 
settings, the various formulas for the estimation of fetal weight have various 
methodological and/or analytical faults. Errors in fetal weight estimation may originate 
from several sources: 1) systematic and random errors in measurement, reflected in 
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inter-and intra-observer variability; 2) combining 2-dimensional measures to approximate 
3-dimensional fetal volume; and 3) the use of fetal volume to estimate fetal weight, a 
measure of mass (i.e. volume*density) (Zhang, Merialdi et al.). Most formulae have an 
overall mean absolute percentage error of less than 10% and no formula has been 
consistently shown to be superior (Dudley 2005; Scioscia, Paine et al. 2008), with 
estimated fetal weight subject to poorer precision in very low and very high birth weight 
babies (Kurmanavicius, Burkhardt et al. 2004; Anderson, Jolley et al. 2007; Scioscia, 
Vimercati et al. 2008).  
Doppler assessment of IUGR 
The most frequently used technique for diagnosing abnormal growth in a fetus is 
to calculate the EFW using ultrasound-derived fetal biometric data and to compare the 
EFW with a fetal growth curve in order to identify fetuses falling under a certain 
percentile. Generally, an EFW below the 10th percentile for gestational age is used to 
identify the potentially growth restricted fetus. However, there is no “gold standard” for 
the identification of IUGR based on EFW and other cutoffs have been suggested, 
including EFW less than the 25th, 5th and 3rd percentiles and an EFW 2 standard 
deviations below the mean (corresponding to approximately the 2nd or 3rd percentile) 
(Pollack and Divon 1992).  
There are many published reference curves for fetal growth; interpretations of the 
estimated fetal weight (or AC) percentile are dependent on the birth weight reference or 
standard used. A birth weight reference represents an entire population, while a 
standard excludes high-risk pregnancies assesses fetal size in comparison to normally 
grown fetuses and is likely of superior clinical utility (Zhang, Merialdi et al.). Furthermore, 
it is known that fetal size is influenced by factors such as race, gender, SES and altitude 
and these confounding factors may explain much of the variation among standard fetal 
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growth curves (Zhang, Merialdi et al.). Finally, while many reference curves have been 
constructed from cross-sectional studies, longitudinal studies are preferable due to 
improved data quality and the ability to study fetal growth, versus fetal size (Zhang, 
Merialdi et al.). Alternatives to population or standard growth curves have been 
suggested to deal with these shortcomings, including mathematical models (Rossavik 
and Deter 1984); customized fetal growth charts (Gardosi 1998); and, regression 
methods (Bukowski, Smith et al. 2007). However, the clinical utility of these methods in 
identifying abnormal fetal size has not been demonstrated (Hutcheon, Zhang et al. ; 
Zhang, Merialdi et al. ; Hutcheon and Platt 2008; Hutcheon, Zhang et al. 2008).  
The pathology of malaria in pregnancy 
Susceptibility to malaria in pregnancy 
Pregnant women, and particularly primigravidae, are more susceptible to P. 
falciparum malaria infection than non-pregnant adults due to a unique phenotypic subset 
of parasites that sequester in the placenta. In malaria-endemic regions, people acquire 
immunity to malaria with continued exposure to the parasites, including acquiring anti-
adhesion antibodies that inhibit parasite adherence to various host receptors (e.g. 
CD36). During malaria in pregnancy, parasite-infected erythrocytes (IEs) sequester in 
the placenta via the adhesion to chondroitin sulfate A (CSA) receptors, located on the 
syncytiotrophoblast lining of the villous surface of the placenta and in the intervillous 
space (Duffy and Fried 1999; Muthusamy, Achur et al. 2004). Anti-adhesion antibodies 
to the CSA-binding parasite appear in multigravidae, but primigravidae lack anti-
adhesion antibodies against this parasite phenotype (Fried, Nosten et al. 1998). Natural 
immunity to CSA-binding parasites builds over the progression of pregnancy and 
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through subsequent pregnancies, likely leading to the differential effects of malaria 
infection on birth outcomes based on gravidity.  
Modification of the immune response during pregnancy (Raghupathy 1997) and 
pregnancy hormones (Roberts, Walker et al. 2001) are also believed to play a role in 
susceptibility to malaria during pregnancy. Immune system modulation during pregnancy 
is characterized by a shift away from inflammatory, cell-mediated immunity (Th1-type), 
with decreases in Th1-type cytokines (e.g. interleukin [IL]-2, interferon [INF]γ and tumor 
necrosis factor [TNF]-α), toward humoral, anti-inflammatory (Th2-type) immunity, with 
increases in Th2-type cytokines (e.g. IL-4, IL-6 and IL-10) (Raghupathy 1997). Th1-type 
immune responses are known to be incompatible with a successful pregnancy and may 
result in fetal rejection (Raghupathy 1997). The bias toward a Th2-type immunity is 
thought to leave the pregnant woman more susceptible to Th1-dependent infections, 
such as malaria (Fievet, Moussa et al. 2001).  
Pathophysiology of malaria in pregnancy 
Plasmodium falciparum placental malaria is characterized by several changes in 
the placenta (Figure 2.2). First, IEs adhere to and sequester in the intervillous space of 
the placenta (Fried and Duffy 1996; Rogerson, Mwapasa et al. 2007). IEs can achieve 
high densities in the placenta (Brabin, Romagosa et al. 2004); and may be retained 
there even after apparently adequate therapy (Procop, Jessen et al. 2001). Second, IEs 
may be accompanied by intervillous infiltrates of monocytes and macrophages, with or 
without malaria pigment (i.e. hemozoin) (Rogerson, Hviid et al. 2007). Intervillous 
infiltrates of inflammatory cells are associated with low birth weight (Leopardi, Naughten 
et al. 1996; Menendez, Ordi et al. 2000; Rogerson, Pollina et al. 2003). Finally, malaria 
pigment may be found in fibrin deposits in the intervillous spaces without active 
parasites, representing past chronic infection (Bulmer, Rasheed et al. 1993). Several 
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studies have found that hemozoin is associated with lower birth weight and lower 
hemoglobin concentrations (Rogerson, Mkundika et al. 2003); however, others have not 
found an association between hemozoin and poor birth outcomes (Sullivan, Nyirenda et 
al. 2000). Several systems have been developed to characterize the pathological 
changes of malaria in pregnancy (Bulmer, Rasheed et al. 1993; Leopardi, Naughten et 
al. 1996; Ismail, Ordi et al. 2000; Rogerson, Pollina et al. 2003).  
The identification of malaria in pregnancy 
The antenatal diagnosis of placental malaria is constrained by the unavailability 
of information regarding placental infection prior to delivery. In pregnant populations, the 
microscopy of peripheral blood smear underestimates the prevalence of placental 
malaria infection using placental blood smear microscopy as referent (Leke, Djokam et 
al. 1999; Rogerson, Mkundika et al. 2003; Akum, Kuoh et al. 2005; Tako, Zhou et al. 
2005), although these findings have not been universal (Kasumba, Nalunkuma et al. 
2000). Generally, microscopy of peripheral thick blood smears during pregnancy is 
considered a poor proxy for placental malaria, as malaria parasites sequestered in the 
placenta may not be in the peripheral blood or may be submicroscopic in the peripheral 
blood (Mockenhaupt, Ulmen et al. 2002).  
PCR of peripheral blood has been shown to have nearly 100% sensitivity with 
placental blood smear as the referent; however, specificity is lower (75%) (Mockenhaupt, 
Ulmen et al. 2002). “False positives” using PCR of peripheral blood may be due to the 
low sensitivity of placental blood smear microscopy (76-78% compared to the gold 
standard referent of placental histology) (Rogerson, Mkundika et al. 2003); peripheral 
parasitemia in the absence of placental infection; and/or remnant DNA in the peripheral 
blood from resolved placental infection. To date, PCR of peripheral blood at delivery and 
the gold standard of placental histology have not been compared. While qPCR is highly 
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sensitive and specific, the clinical relevance of submicroscopic infections is under debate 
(Mankhambo, Kanjala et al. 2002; Malhotra, Dent et al. 2005; Mockenhaupt, Bedu-Addo 
et al. 2006). 
Malaria in pregnancy, placental function and fetal growth  
Malaria in pregnancy is thought to affect fetal growth primarily through placental 
insufficiency, although the exact mechanisms are unclear and are likely to be 
multifactorial (Figure 2.3). Chronic malaria infection is particularly associated with the 
risk of low birth weight and asymmetrical growth, while preterm is associated with acute 
infection and high parasite densities (Brabin, Romagosa et al. 2004; Rogerson, Hviid et 
al. 2007; Rogerson, Mwapasa et al. 2007). There are several hypothesized pathological 
mechanisms of malaria in pregnancy believed to affect placental function and fetal 
growth including: 1) disrupted trophoblast invasion and inadequate spiral artery 
remodeling, resulting in decreased placental blood flow; 2) placental inflammatory 
infiltrates physically decreasing blood flow in the placenta or releasing Th1-type 
cytokines; 3) morphologic changes in the placenta and placental lesions; and 4) 
maternal anemia.  
A potential mechanism by which malaria in pregnancy may impact fetal growth is 
via the disruption of trophoblast invasion and the process of spiral artery remodeling 
from malaria infection during early pregnancy (Dorman, Shulman et al. 2002; Rogerson 
and Boeuf 2007). The peak prevalence of infection in primi- and multigravidae occurs 
from approximately 13 to 20 weeks’ gestation; coinciding with the second wave of 
trophoblast invasion of the maternal spiral arteries (Brabin 1983; Dorman, Shulman et al. 
2002). If the process of spiral artery remodeling is impaired, it may lead to inadequate 
blood flow later in pregnancy, similar to preeclampsia.  
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The most significant association with active malaria infection is the intervillous 
infiltration by inflammatory cells, particularly in primigravidae, who lack a significant Th2-
type anti-inflammatory response (Brabin, Romagosa et al. 2004). P. falciparum infection 
favors the Th1-type, inflammatory immune response, with increased levels of TNF-α; 
IFNγ; and IL-12 (Fievet, Moussa et al. 2001). TNF-α and IFNγ have direct cytotoxic 
effects toward both intracellular organisms and the villous trophoblast (Brabin, 
Romagosa et al. 2004). Both placental levels of Th1-type cytokines and inflammatory 
infiltrates in the intervillous space have been consistently associated with low birth 
weight (Leopardi, Naughten et al. 1996; Menendez, Ordi et al. 2000; Rogerson, Pollina 
et al. 2003). Birth weight reduction is particularly dramatic in the case of massive chronic 
intervillositis (Ordi, Ismail et al. 1998; Menendez, Ordi et al. 2000). Placental infiltration 
of inflammatory cells, infected erythrocytes and fibrin can be massive, with more than 
three-quarters of the intervillous space involved with infiltration (Ordi, Ismail et al. 1998). 
These inflammatory infiltrates may decrease placental blood flow mechanically. 
Intervillous infiltrates may also contribute to the effect of malaria in pregnancy on fetal 
growth via damage to the villous trophoblast or the release of Th1-type cytokines. 
There are several morphologic and vascular changes that have been consistently 
found to characterize active infection in malaria in pregnancy, including perivillous 
fibrinoid deposits, increased syncytial knotting; and trophoblastic basement membrane 
thickening (Bulmer, Rasheed et al. 1993; Ismail, Ordi et al. 2000; Brabin, Romagosa et 
al. 2004). These changes are associated with damage to the syncytiotrophoblast and to 
cytotrophoblast proliferation (Bulmer, Rasheed et al. 1993; Brabin, Romagosa et al. 
2004). [It is worth noting that past infections show minor histological abnormalities, 
indicating that resolved placental malaria infections leave few to no residual changes in 
the placenta (Brabin, Romagosa et al. 2004)]. Trophoblastic basement membrane 
thickening is seen in both acute and chronic infections (Bulmer, Rasheed et al. 1993); 
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however, most of these changes are typically seen in chronic infection or severe 
parasitemia (Brabin, Romagosa et al. 2004; Rogerson, Hviid et al. 2007). These 
placental lesions, particularly the thickening of the trophoblastic basement membrane 
(Bulmer, Rasheed et al. 1993), may alter nutrient transport and could contribute to the 
effect of malaria in pregnancy on fetal growth.  
Malaria induced maternal anemia is an additional mechanism through which 
maternal malaria may impact fetal growth. Maternal iron-deficiency anemia often 
accompanies maternal undernutrition, which may confound the association between 
anemia and fetal growth.  Anemia might contribute to changes in placental growth and 
vascular structure, leading to hypoxia and reduced nutrient exchange (Mayhew, 
Charnock-Jones et al.). In malaria in pregnancy, increased TNF-α and monocyte 
infiltrates are associated with maternal anemia (Fried, Muga et al. 1998; Rogerson, 
Pollina et al. 2003). Moderate to severe anemia is a recognized cause of low birth weight 
(Rasmussen 2001; Levy, Fraser et al. 2005). The relationship between maternal malaria, 
maternal anemia and low birth weight is complicated by the finding that iron deficiency 
anemia may confer protection from placental malaria, particularly in primigravidae 
(Kabyemela, Fried et al. 2008). 
Previous studies, gaps in knowledge and summary 
Two cross-sectional studies have previously reported an association between 
malaria and abnormal utero- and fetoplacental blood flow. In Kenya, peripheral malaria 
infection during the third-trimester was  associated with concurrent bilateral uterine 
artery notching, with 18.3% of women with peripheral parasitemia having bilateral 
notching, compared to 8.2% of women who were not parasitemic (RR=2.24; 95% CI: 
1.31, 3.83) (Dorman, Shulman et al. 2002). Among pregnant women experiencing acute 
malaria crises in French Guinea, Doppler indices were abnormal, with umbilical artery 
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resistance increasing by 5 to 20%; uterine artery resistive indices were also increased in 
approximately half of the pregnancies (Arbeille, Carles et al. 1998). These studies 
provide evidence that at least some malaria-associated IUGR is explained by decreased 
utero- and fetoplacental blood flow. However, the effects of malaria parasitemia have yet 
to be explored longitudinally over the course of pregnancy. 
It has also been hypothesized that malaria infection during early pregnancy 
affects the process of trophoblast invasion and remodeling of the maternal spiral 
arteries, as in preeclampsia (Rogerson and Boeuf 2007). Should malaria in early 
pregnancy affect trophoblast invasion, it could lead to altered uterine artery blood flow, 
reduced oxygen and nutrient exchange, and, ultimately, intrauterine growth restriction. 
To date, this hypothesis has not been tested. The potential for malaria parasitemia to 
alter fetoplacental blood flow has not been discussed in the literature. However, malaria 
in early pregnancy could also affect villous angiogenesis in the placenta. To date, the 
effect of malaria during early pregnancy on uterine and umbilical artery blood flow over 
the course of pregnancy has not been explored. 
There is a considerable literature linking malaria in pregnancy to low birth weight 
at delivery (Cot, Le Hesran et al. 1995; Steketee, Wirima et al. 1996; Verhoeff, Brabin et 
al. 1998; Menendez, Ordi et al. 2000); and, due to the difficulties of accurate pregnancy 
dating, a smaller number of studies showing a small, significant increased risk of SGA at 
delivery (Steketee, Wirima et al. 1996; Sullivan, Nyirenda et al. 1999; Verhoeff, Brabin et 
al. 2001). Placental malaria has also been found to be associated with an increased risk 
of SGA at delivery (Steketee, Wirima et al. 1996; Menendez, Ordi et al. 2000; Verhoeff, 
Brabin et al. 2001). An important limitation of these studies is that they have described 
the association of antenatal and/or placental malaria infection and fetal weight cross-
sectionally at delivery.  
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Evidence is mounting that early pregnancy malaria infection is associated with 
decreased fetal weight at delivery. To our knowledge, three previous studies have 
examined various definitions of early pregnancy malaria exposure with birth weight or 
low birth weight outcomes (Table 2.1). These studies appear to demonstrate a j- or u-
shaped relationship between the timing of malaria exposure and both decreased birth 
weight and risk of low birth weight (Taha, Gray et al. 1993; Cottrell, Mary et al. 2007; 
Huynh BT 2011). While studies describing effect of early pregnancy malaria infection on 
fetal growth are of interest, inaccurate pregnancy dating and a lack of longitudinal fetal 
growth data have prevented such analyses, to date. 
In summary, there are important gaps in knowledge regarding the relationship 
between acute and early pregnancy malaria on utero- and fetoplacental blood flow and 
fetal growth. The relationship between malaria and utero- and fetoplacental blood flow 
has not been explored longitudinally. Additionally, the effect of malaria during early 
pregnancy on utero- and fetoplacental blood flow and fetal growth has not been 
examined. Thus, questions remain regarding when and how malaria in pregnancy leads 
to increased uterine and umbilical artery resistance and reduced fetal growth, for 
example: Is it an acute process? Does parasitemia in early pregnancy affect trophoblast 
invasion and lead to impaired uteroplacental circulation, as in preeclampsia? Does the 
effect of malaria on blood flow and fetal growth change over pregnancy? Answers to 
questions such as these can lead to a better understanding of the pathogenesis of 
malaria in pregnancy; a better understanding of disease processes can be used to 
inform the type and timing of public health interventions, leading to improved health 
outcomes for mothers and their infants. 
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Figure 2.1 Typical umbilical artery Doppler with Doppler Index equations. S is peak 
systole; D is end-diastole; A is the temporal average frequency; RI is resistance index; 
PI is pulsatility index. 
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Figure 2.2 Histologic features of placental malaria. IVS=intervillous space; V=placental 
villi; F=fibrin; arrowheads=infected erythrocytes; asterisk = inflammatory cells; circle = 
pigment (hemozoin versus formalin artifact). Giemsa stain, 400x. (Image courtesy of Atis 
Muehlenbachs)
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Figure 2.3 Possible pathways by which placental sequestration of infected erythrocytes 
could activate monocytes and other cells to cause changesin placental function that 
result in growth retardation. Infected erythrocytes or their products can activate both 
syncytiotrophoblasts and monocytes to release chemokines and cytokines. The former 
contribute to monocyte accumulation, whereas the latter could have direct effects of 
placental growth (through angiogenesis). Cytokines and cell accumulations can lead to 
placental hypoxia. Cytokines could directly or indirectly affect nutrient transport 
mechanisms. Decreased placental growth, or decreased nutrient transport are probable 
final common pathways by which malaria leads to fetal growth restriction. Glut1=glucose 
transporter 1. (Rogerson, Hviid et al. 2007). 
 2
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Table 2.1 Association between early pregnancy malaria infection and pregnancy outcomes. 
Location Design N Outcome Timing Effect type Effect (95% CI) Citation 
        
Benin Cohort 1037 Birth weight <4 months Mean difference -98.5 g
a
 (-189, -9) (Huynh BT 2011) 
    5-6 months Mean difference 35.4 g (-42, 113)  
    >6 months Mean difference -22.0 g (-82, 39)  
   LBW <4 months Odds Ratio 1.2 (0.6, 2.6)  
    5-6 months Odds Ratio 1.0 (0.5, 2.0)  
    >6 months Odds Ratio 1.4 (0.8, 2.5)  
        
Burkina Faso Cohort 1190 Birth weight <4 months Mean difference -68 g
b 
(-145, 10)
 
(Cottrell, Mary et al. 2007) 
    4-6 months Mean difference 18 g (-68, 101)  
    >6 months Mean difference -105 g (-190, -22)  
   LBW <4 months Odds ratio 1.3 (0.7, 2.4)  
    4-6 months  Odds ratio 1.1 (0.6, 1.8)  
    >6 months Odds ratio 1.8 (1.1, 3.1)  
        
Central Sudan Case-control 215/117 LBW Trimester 1 Odds ratio 1.9
c
 (1.2, 2.7) (Taha, Gray et al. 1993) 
    Trimester 2  Odds ratio 1.6 (1.0, 2.6)  
    Trimester 3  Odds ratio 1.3 (0.4, 4.1)  
        
LBW = Low birth weight; LBW was defined as <2500 grams in all studies 
a. Models adjusted for parity, newborn sex, rainy season at delivery, maternal BMI, education, duration of gestation, number of SP intakes, 
number of consultations, bednet use 
b. Models adjusted for parity; infant sex; transmission period; maternal BMI; duration of gestation; prophylaxis before and after 6 months of 
pregnancy 
c. Models adjusted for malaria treatment, use of insecticides, parity, other illnesses, infant sex, antenatal care, maternal weight 
  
CHAPTER 3 - METHODS 
Study Design 
In order to investigate the specific aims of this dissertation, we conducted 
secondary analyses using data from the “Project ECHO” study. Project ECHO was a 
longitudinal Doppler ultrasound cohort study conducted in Kinshasa, Democratic 
Republic of Congo. Project ECHO data uniquely provide the ability to examine the 
relationship between malaria and fetal size for several reasons: 1) ultrasound dating of 
gestational age; 2) prospective serial measures of Doppler fetal biometrics and blood 
flow velocity waveforms; and 3) prospective serial measures of incident malaria 
parasitemia. The Project ECHO study has continuing UNC Institutional Review Board 
(IRB) approval. 
Study Setting and Population 
Project ECHO was conducted in the Binza Maternity Hospital in Kinshasa, 
Democratic Republic of Congo and was a collaboration of University of North Carolina-
Chapel Hill School of Public Health and the Kinshasa School of Public Health. Binza 
Maternity Hospital has been in operation for over 30 years and is Kinshasa’s second 
largest urban maternity hospital, with between 6,000 and 10,000 births per year.  
Pregnant women who presented for first antenatal care at Binza Maternity 
Hospital in Kinshasa, Democratic Republic of Congo during two recruitment stages 
between May 2005 and May 2006 were considered for enrollment in the study. Women 
aged 18 or older, with a singleton pregnancy with no known fetal congenital 
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malformations and an ultrasound-derived gestational age of 22 weeks, 0 days or less 
were considered eligible for enrollment.  
Selection Criteria 
Inclusion criteria: In order to be eligible for the study, women had an ultrasound 
confirmed singleton pregnancy with an ultrasound-derived gestational age of 22 weeks, 
0 days or less; were 18 years of age or older; agreed to HIV testing; and consented to 
participate in the study.  
Exclusion criteria: Women were excluded who were younger than 18 years of 
age; had a fetus with detectable congenital malformations; or, were hypertensive 
(systolic blood pressure >140 mmHg and/or diastolic > 90 mmHg) at baseline. Women 
with evidence of placenta previa, fetal abnormalities and multiple gestations during 
ultrasound were referred to the Department of Obstetrics and Gynecology at the Clinique 
Universitarie in Kinshasa for high-risk pregnancy follow-up care. 
Data Collection 
Recruitment 
During routine antenatal registration and clinical evaluation at Binza Maternity 
Hospital, all pregnant women presenting for their first antenatal care visit were screened 
for study pre-eligibility. The three pre-eligibility criteria were: 1) aged 18 or older; 2) 
systolic blood pressure less than 140 mmHg and diastolic blood pressure less than 90 
mmHg; and, 3) less than 23 weeks gestation by patient reported last menstrual period. 
Women who met pre-eligibility criteria were asked to consent to have a baseline 
ultrasound examination to estimate gestational age (Hadlock, Deter et al. 1984; Hadlock, 
Shah et al. 1992) and fetal weight (Hadlock, Harrist et al. 1985) within three to five days 
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of pre-eligibility screening. Amniotic fluid volume index (four quadrant method), gender of 
the fetus and placental location were also recorded. Pre-eligible women having an 
ultrasound-confirmed singleton pregnancy less than 22 weeks, 0 days were considered 
eligible for the Project ECHO study. Eligible women met with a Project ECHO recruiter 
who explained the objectives and procedures of the longitudinal study and administered 
written informed consent for enrollment. Results from recruitment are reported in Figure 
3.1. 
Baseline visit 
After providing written consent, enrolled women participated in the baseline 
interview to assess sociodemographic characteristics; medical and obstetric history; 
alcohol and tobacco use; and, current malaria status. All enrolled women participated in 
HIV voluntary counseling and testing at baseline via an ongoing Glaser Foundation 
Preventing Mother to Child Transmission program conducted at Binza Maternity 
Hospital. Woman identified as HIV-positive, and their infants, received Nevirapine 
treatment as per the Glaser Foundation program protocol. 
A baseline medical examination collected maternal anthropometric 
measurements (weight, height and mid-upper arm circumference); blood pressure; 
pulse; temperature; and pallor. The onsite Binza Maternity Hospital laboratory conducted 
a urine test for albumin and a hematocrit test. The laboratory collected malaria thick and 
thin smears and filter paper samples from fingerprick blood samples. Malaria thick 
smears were read onsite via microscopy for a gross determination of parasitemia. The 
Ecole Sante Publique de Kinshasa provided quality control; assessment of parasite 
density; and, parasite speciation via microscopy. 
In accordance with Congolese National Policy, all enrolled women received a 
dose of intermittent presumptive therapy in pregnancy (IPTp) with sulfadoxine-
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pyrimethamine (SP: 1500 mg sulfadoxine + 75 mg pyrimethamine) between 16 and 27 
weeks’ gestation, regardless of malaria status. If women had their baseline visit prior 16 
weeks’ gestation, they received IPTp at their first follow-up visit. In accordance with 
Congolese National Policy, women received iron supplementation as part of routine ANC 
at Binza Maternity Hospital. At the end of the baseline visit women were provided with 
an insecticide treated bed net. 
Follow-up visits 
Participants returned to Binza Maternity Hospital for monthly follow-up visits until 
delivery. At each follow-up visit, a medical examination assessed maternal weight and 
mid-upper arm circumference; blood pressure; pulse; temperature; and symptoms of 
anemia. The Binza Maternity Hospital laboratory conducted a urine test for albumin at 
each follow-up visit and a hematocrit test at every other visit. A follow-up interview 
assessed recent malaria symptoms, use of anti-malarial medications, and bed net use. 
At each follow-up visit, an ultrasound examination was used to estimate 
gestational age and fetal weight from fetal biometric measurements; amniotic fluid 
volume index; and, placental location. Doppler ultrasound additionally interrogated left 
and right uterine and umbilical artery blood flow waveforms; arterial notching of the 
uterine arteries; and end diastolic flow of the umbilical artery. 
The onsite laboratory collected malaria thick and thin smears and filter paper 
samples from finger-prick blood samples. Malaria thick smears were read onsite via 
microscopy for a gross determination of parasitemia, with quality control from Ecole 
Sante Publique de Kinshasa. At all visits, women found to have a positive malaria slide 
were provided with free anti-malarial treatment by Project ECHO, with treatment 
determination by the attending physician at Binza Maternity Hospital. In accordance with 
Congolese National Policy, all enrolled women received a second dose of intermittent 
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presumptive therapy (IPT) with SP between 28 and 32 gestational weeks, regardless of 
malaria status. 
Interim visits 
Women were instructed to return to the clinic any time they felt ill or had malaria 
symptoms. At interim visits, the maternity provided regular medical care. A Project 
ECHO staff member recorded all medical procedures performed/medications prescribed 
and prepared a thick smear and filter paper sample from finger prick blood samples. All 
medications and laboratory tests were provided free of charge by Project ECHO. 
Labor and Delivery 
Project ECHO participants were encouraged to deliver at Binza Maternity 
Hospital and were reimbursed for one-third of delivery-related fees. If a study participant 
did not delivery at Binza Maternity Hospital, a Project ECHO staff member traveled to 
the hospital or clinic where the woman delivered as soon after delivery as possible to 
collect the necessary samples and infant information. 
Prior to delivery, the onsite laboratory collected malaria thick and thin smears 
and filter paper samples from finger-prick blood samples and conducted a hematocrit 
test. If biospecimen samples were not collected prior to delivery, attempts were made to 
collect them in the 24 hours following delivery. Delivery date, method, abnormal events 
and outcome were recorded. After delivery, a placental thick smear and a placental 
biopsy were taken to assess placental malaria infection. The infant was weighed, gender 
and congenital malformations were noted, and infant anthropometrics (crown to heel, 
crown to rump, head circumference and abdominal circumference) were taken within 24 
hours of delivery.  
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Enrolled women participated in 979 regular appointments that included an 
ultrasound scan, with 11 in the first trimester, 423 in the second trimester and 545 in the 
third trimester. There were 172 interim visits which did not include an ultrasound scan. 
Women participated in 4.5 follow-up visits (SD = 0.9 visits) and were enrolled for 18 
weeks (SD = 3 weeks) on average. Delivery information was collected for 180 women 
(no data for one maternal death and one woman with unknown delivery location). There 
were 167 term deliveries, 8 preterm deliveries, 3 preterm/stillbirth deliveries, and one 
preterm/early neonatal death. The results of follow-up and delivery can be seen in Figure 
3.2 
Measurements 
Measurements taken at baseline, follow-up and delivery are summarized in Table 
3.1. A description of ultrasound, biological and clinical measures relevant to the 
proposed analyses follows as previously described (Landis 2007). 
 
Ultrasound measures 
Ultrasound measurements were taken on the GE Logicbook Ultrasound System. 
Ultrasound images were stored on CD-ROM for blinded quality control at University of 
North Carolina-Chapel Hill. Victor Lokomba, an obstetrician-gynecologist from Clinique 
Universitarie in Kinshasa with extensive training in ultrasound technique, performed all 
ultrasound measures. 
Fetal biometric measures 
All fetal biometric measures were measured using standard techniques. 
Measurements of head circumference (HC) and biparietal diameter (BPD) were from an 
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image that displayed the fetal head in an axial plane that included the thalamus and 
cavum septum pellucidum. The BPD was measured by placing the calipers from leading 
edge to leading edge (outer to inner skull table) and the HC was measured using an 
ellipse trace of the outline of the fetal head. Abdominal circumference (AC) was 
measured from an image in which the junction of the umbilical vein and portal sinus were 
visible. The ellipse function was used to trace the extreme perimeter of the fetal 
abdomen. Femur length (FL) of the femoral diaphysis was also measured. A 10% 
sample of ultrasound images was assessed for quality by a maternal-fetal medicine 
physician at the University of North Carolina - Chapel Hill. Ninety-two percent of 
reviewed images were rated adequate for clinical assessment; 7% of questionable 
quality and 1% of poor quality (i.e. not all biometry landmarks clearly visible; shadowing 
in the image; or, poor tracing of the length of circumference). Intra-operator variability in 
measuring fetal biometry was assessed in ten patients. The correlation between two 
independent measurements on the same fetus was r=0.99 for each of BPD, HC, and FL, 
and r=0.98 for AC. 
Uteroplacental blood flow 
Color Doppler ultrasound used standard techniques to identify the left and right 
uterine arteries and umbilical artery. For each of the uterine arteries, color flow settings 
identified the external iliac artery and uterine artery located perpendicular and medial to 
it. Flow velocity waveforms were obtained from the uterine artery near the iliac vessel 
prior to division of the uterine artery into branches. For the umbilical artery, the flow 
velocity waveform was obtained from the free flowing portion of the umbilical cord 
approximately midway between placental and fetal insertion sites. Left/right uterine and 
umbilical artery measures included the systolic-diastolic (SD) ratio, resistance index (RI) 
and pulsatility index (PI). For the uterine arteries, there was a qualitative assessment of 
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the presence of early diastolic notching. For the umbilical artery, there was an 
assessment of end-diastolic flow, with absent or reversed end-diastolic (ARED) flow 
noted. 
Biological and clinical measures 
Malaria 
At baseline, follow-up visits, interim visits and at delivery, blood was collected 
and prepared as a thick and thin smear, and applied to filter paper, using standard 
techniques.  Thick and thin smears were taken from the site of a finger puncture, were 
dried and Giemsa-stained. Five dried blood spots were collected by lightly touching a 
filter paper to a large blood drop from the sight of finger puncture. Filter papers with dried 
blood spots were placed in individual plastic bags with desiccant; stored at -20 C; and, 
were transported to UNC. Malaria parasitemia was assessed in two ways: microscopy 
and real-time PCR. 
Microcopy-Determination of Peripheral Malaria Parasitemia 
Peripheral malaria parasitemia was assessed from Giemsa-stained thick smears 
on-site by a trained microscopist. Parasite sub-type was determined and density was 
quantified by counting the number of parasites against 200 white blood cells and 
converted to numbers of parasites per µl, assuming 6000 WBC per µl. All specimens 
were sent to the Ecole Sante Publique de Kinshasa for a second assessment of sub-
type and density. If discrepancies occurred, a third reader assessed the slide. For quality 
assurance purposes, a random sample of 10% of all blood smears was blindly assessed 
by a second trained microscopist.  
Real-time qualitative PCR-Determination of Peripheral Malaria Parasitemia   
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At University of North Carolina – Chapel Hill, three 0.6 cm diameter punches 
were punched from each dried blood spot filter paper card and were deposited into a 
single well of a 96-well deepwell plate. Genomic DNA was extracted from plates of 
punches using the QIAamp 96 DNA Blood Kit (Qiagen, Germantown, Maryland, USA) 
with a vacuum manifold according to the manufacturer’s protocol. Genomic DNA was 
eluted into 150uL of eluate and stored at 4C. Primer and probe sequences to the block 9 
region of the gene encoding the small subunit (18S) of plasmodia ribosomal RNA were 
modified from a published protocol which detected between 1 to 10 copies of the target 
DNA and was specific to plasmodia 18S DNA. qPCR was carried out in 25uL reactions 
consisting of 2uL of DNA, 12.5uL of 2x TaqMan Universal PCR MasterMix (Applied 
Biosystems, Foster City, California, USA), forward and reverse primers at 1000nM and 
VIC-labeled minor-groove binding probe at 200nM.  Cycling conditions on an Applied 
Biosystems 7300 System were 50C for 2 minutes, 95C for 10 minutes and 40 cycles of 
95C for 15 seconds and 60C for 1 minute. The ability of the assay to detect different 
malaria species and strains was evaluated by testing the assay with genomic DNA from 
Plasmodium falciparum strain 3d7 (MRA-102G, MR4, ATCC, Manassas, VA), genomic 
DNA from P. vivax strain Nicaragua (MRA-340G; MR4), and plasmids containing the 
18S ribosomal DNA gene from P. falciparum, P. vivax, P. ovale and P. malariae (MRA-
177, MRA-178, MRA-179, MRA-180, respectively; MR4).  The sensitivity of the assay 
was determined by evaluating dilutions of P. falciparum genomic DNA (Taylor, Juliano et 
al. 2010). 
Maternal anthropometrics 
Standard techniques (NHANES 1998) were used to assess maternal weight, 
height and mid-upper arm circumference (MUAC). Maternal weight was measured on a 
UNICEF digital scale (SECA Model 890) to the nearest 0.1 kilogram. Height (without foot 
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or head-wear) was measured to the nearest 0.1 cm. MUAC was measured with cloth 
tapes on the right arm at the midpoint between the acromial and olecranon processes of 
the scapula and ulna, respectively. The measurement was made to the nearest 0.1 cm 
with the arm hanging freely; the cloth tape snug to the skin; and, without compressing 
underlying tissue. There were technical problems with the digital scale halfway through 
the study period; as such, MUAC measurements were used for all proxy measures of 
maternal nutritional status in this dissertation. 
Infant anthropometrics 
Standard techniques (NHANES 1998) were used to assess infant 
anthropometrics within 24 hours of delivery. Birth crown-heel and crown rump length 
were measured using a pediatric length board; head and abdominal circumference were 
measured to the nearest 0.1 cm using a measuring tape; and, birth weight was recorded 
to the nearest gram on a LARIO Scale (Soc Curion & Co., Como, Italy).  
Data Management and Analysis 
Data entry was completed in the Democratic Republic of Congo using an EpiInfo 
database designed specifically for the Project ECHO study, with multiple quality control 
mechanisms, including 1) routine checking for complete data at the maternity prior to the 
end of each appointment; 2) pre-programmed ranges of plausible values for all 33 
continuous numeric data fields (e.g., temperature, height, weight); 3) preprogrammed 
ranges of allowable values for all categorical responses; 4) preprogrammed skip 
patterns; 5) required data entry fields (such as ID numbers and dates) that must be 
entered to continue with entry; and vi) re-entry of a 10% sample of forms by an 
independent data entry clerk for comparison to the larger database using the EpiInfo 
Data Compare function. 
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The EpiInfo data base was transferred into SAS and SPSS datasets for data 
cleaning. Data cleaning steps included: 1) identifying data that is missing from required 
fields and attempting to locate that data if possible; 2) checking to ensure that skip 
patterns were properly followed; 3) descriptive statistics of all continuous variables to 
identify outlier values; 4) ensuring that dates match up on all forms for a given visit; 5) 
translating dates into American format (DD/MM/YYYY); and, 6) adding descriptive labels 
and user defined formats to each variable. 
All information in the Project ECHO database is de-identified.  
Specific Aim 1 Analyses 
Using longitudinal Doppler ultrasound cohort data, Aim 1 examined the effect of 
malaria parasitemia on changes in uterine artery (UtA) and umbilical artery (UA) 
resistance indices (RI) over time.  
Study population 
Five participants were HIV-positive and were excluded from the analysis, leaving 
a final analytic sample of 177 women, with a total of 1120 antenatal visits. HIV-positive 
women were not different from the final analytic sample of women by model covariates. 
Participants had a median of 6 visits (interquartile range [IQR]: 5, 7) and 4 ultrasound 
scans (IQR: 4, 5). 
Variables 
Exposure: 
Malaria: The primary malaria exposure variable was based on qPCR for P. 
falciparum malaria from peripheral dried blood samples. ‘Malaria’ was a binary, time-
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dependent measure representing whether a woman was positive for P. falciparum 
malaria at the visit in which the ultrasound measure of uteroplacental blood flow were 
taken. Malaria was treated dichotomously: 0 (no malaria) and 1 (malaria). We removed 
suspected recrudescent malaria cases if parasitemia recurred within two weeks of 
treatment for a blood smear identified infection (6 episodes). Due to the substantial 
misclassification of microscopy-determined malaria parasitemia in the current dataset 
(Taylor, Juliano et al. 2010); the higher detection threshold of microscopy; and, the 
potential for poor microscopy sensitivity and specificity (Ohrt, Obare et al. 2007), for all 
proposed analyses the primary time-dependent malaria exposure was defined as qPCR-
positive Plasmodium falciparum parasitemia from peripheral blood. 
Outcome: 
Outcome variables for placental blood flow included the continuous, time-
dependent mean of the left and right uterine artery (UtA) and the umbilical artery (UA) 
resistance index (RI) after 20 weeks’ gestation. The RI is defined as: (peak systolic 
velocity – end diastolic velocity) / peak systolic velocity.  The RI is constrained between 
0 and 1; demonstrates the least variance of the Doppler indices under identical 
hemodynamic conditions; is common in clinical settings; and, has a truncated normal 
distribution (Maulik 2005). Placental location influences the uterine artery waveform and 
there are differences in the Doppler indices of the placental and non-placental uterine 
arteries, generally with lower indices on the placental side (Kofinas, Penry et al. 1988). 
We utilized the mean of the two uterine artery resistance indices at each study visit to 
minimize the effects of placental location on the resistance index. 
Time metric:  
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Gestational age was back-calculated from the first ultrasound using Hadlock’s formula: 
Gestational age = 10.85 + 0.060*HC*FL + 0.6700*BPD + 0.1680*AC (Hadlock, Deter et 
al. 1984). As previously discussed, the derivation of gestational age from early 
ultrasound assumes no significant variability in growth at the pregnancy dating 
ultrasound and will bias estimates for the large fetus (upward) or small fetus (downward). 
However, ultrasound dating is still considered a reasonably accurate estimate of 
gestational age (Chervenak, Skupski et al. 1998). The ‘gestational age’ variable was 
centered in order to achieve a meaningful intercept that can be interpreted as the 
resistance index occurring at gestational week 28. 
Hypothesized effect measure modifiers:  
Gestational age: The interaction between the malaria exposure and gestational 
age were investigated to determine if the effects of malaria on UA RI and UtA RI vary 
over the course of pregnancy. 
Primigravidity: As malaria is known to have a differential effect on birth outcomes 
in primigravidae (Desai, ter Kuile et al. 2007), gravidity was explored as a potential effect 
measure modifier. Primigravidity was coded dichotomously as primigravidae (1) or 
multigravidae (0). 
Fetal sex: Fetal sex has never, to our knowledge, been investigated as a modifier 
of the relationship between malaria and pregnancy outcomes. However, recent work by 
Clifton et al. regarding the sex-specific adaptations of the placenta in asthma, pre-
eclampsia, and preterm delivery (Clifton 2010) inspired our investigation of fetal sex a 
potential effect measure modifier. Fetal sex was coded dichotomously as female (1) or 
male (0).  
Baseline maternal upper arm circumference: As maternal nutritional status has 
been shown to modify the effects of malaria on pregnancy outcomes (Landis, Lokomba 
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et al. 2009), we explored mid-upper arm circumference (MUAC) as a modifier of the 
relationship between malaria and pregnancy outcomes. MUAC is an indicator of 
maternal nutritional status that is relatively unaffected by gestational age and is a better 
proxy for pre-pregnancy weight than maternal BMI (Krasovec and Anderson 1991). 
Further, as there was a malfunction in the digital scale approximately halfway through 
the study period, we utilized MUAC for all proxy variables for maternal nutritional status 
in all analyses. Women with baseline MUAC in the lowest quartile (<24.5 cm) were 
classified as ‘Low MUAC.’ 
Covariates:  
Potential confounders were identified through a review of the literature and were 
analyzed via a directed acyclic graph (DAG) (Figure 3.3). Only relationships between the 
exposure, outcome and covariables are shown; relationships between covariates were 
considered, but are not depicted to simplify the graph. DAG confounders included 
maternal age, low education (<secondary vs. ≥secondary); low socioeconomic status 
(SES) (low vs. high). We did not consider antimalarials, ITN use, or number of ANC 
visits in the models as we did not find that they were associated with our outcomes in the 
literature. 
Maternal age: Maternal age was measured continuously, but was categorized in 
the analysis (18-24, ≥30 years vs. 25-29 years) to better fit the well-described u-shaped 
relationship with adverse pregnancy outcomes. 
Low education: ‘Low educational status’ was a binary variable defined as women 
who had less than a secondary education vs. women with a secondary education or 
higher. 
Socio-economic status (SES): ‘Low SES’ was a binary composite variable, with 
women meeting all of the following criteria categorized as ‘low SES’: currently 
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unemployed; living in a home without toilet facilities; no access to a nearby water source; 
and, no electricity. 
Data analyses 
Univariate and bivariate analyses 
We conducted exploratory analyses to examine cross-sectional and longitudinal 
relationships in the data. We plotted individual outcome measurements over time and fit 
ordinary least squares and nonparametric trajectories. We examined polynomial 
transformations of gestational age visually to determine which individual change 
trajectory best described the relationship between time and the outcome variables. To 
explore inter-individual differences in change, we graphed a random sample of 20 
smooth nonparametric and OLS regression trajectories. We also smoothed average 
trend lines for covariate subgroups to investigate group differences in trajectories. 
Finally, we plotted individual profiles with the smoothed average trend line using a spline 
routine.  
Standard descriptive statistics were examined for the entire dataset and 
aggregated by subject. For continuous measures we examined standard measures 
including means, medians, standard deviations, and quartiles. For categorical variables, 
we examined frequencies and percents at each level of the covariate, including missing 
values. We examined the proportion of missing values for all variables and outliers. We 
examined descriptive statistics for our continuous outcome variables, without 
consideration of repeated measures. 
For bivariate analyses, we examined graphs of nonparametric growth trajectories 
separately for time-independent categorical covariates. We examined associations 
between outcomes, exposures, and covariates, using standard bivariate analyses. We 
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fitted linear mixed effect (LME) models to estimate simple mean differences and 
corresponding 95% confidence intervals (CIs) in UtA RI and UA RI by covariates, 
adjusting for gestational age (Laird and Ware 1982). 
Linear mixed effect models: 
As we utilized LMEs for our multivariable analyses, a brief overview of LME 
methods is included. LME models are appropriate for modeling the association among 
repeated measurements. LMEs can be thought of as a series of nested models, 
representing within-subject change and between-subject change. If ijY  represents the 
continuous outcome for subject i at measurement occasion j; and, ijT  represents the 
time metric for subject i at measurement occasion j. 
The within-subject change model (level 1) is: 
ijijjjij TY   10 where ij ~ N(0,
2
ij
 ). 
And, the between-subject difference in change model (level 2) is: 
jj 0000    
jj 1101    
where






























j
j
j
j
jj
jj
MVN
1
2
,
,0
2
1
0
10
10
,
0
0
~






 
Then, the nested LME model with random intercepts and slopes is: 
ijijjjijij TTY   )()( 101000  
The average subject-specific intercept is represented by 00 ; j0  represents the 
subject-specific random effect (i.e. the random intercept) and is ~ N(0,
2
0 j
 ). The 
average subject-specific slope is represented by 10 ; j1  represents the between-
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subject random effect (i.e. the random slope) and is ~ N(0,
2
1 j
 ). The random effects are 
assumed to be independent from ij , but are not independent of one another, with 
covariance 
jj 10 ,
 . 
Multivariable analyses 
We utilized LME models to estimate the unadjusted and adjusted mean 
differences in the mean uterine artery resistance index and in the umbilical artery 
resistance index with corresponding 95% confidence intervals (CI) (Laird and Ware 
1982). LME models are flexible regression tools to represent change processes in 
longitudinal data and account for the correlation between repeated measures in an 
individual (Laird and Ware 1982). Strengths of LME models include handling data with 
subjects observed at different time points; use of all available data; providing valid 
standard errors and efficient statistical testing. 
Multivariable model building occurred in several steps. We began with a fully 
adjusted LME model, including the dichotomized exposure (malaria), the time metric, the 
product interaction term between the exposure and the time metric, and hypothesized 
product interaction terms and covariates that were potential confounders of the 
association between malaria and the outcomes. We included a random intercept for 
each woman. First, we assessed linearity between gestational age and the outcome by 
examining polynomial transformations of gestational age graphically and using -2 log-
likelihood (-2LL) tests for nested models using maximum likelihood [ML] estimation (a 
priori cutoff of p < 0.10). 
Second, we examined the contribution of additional random effects to model fit 
using -2LL tests for nested models with ML estimation and a 50:50 mixed chi-square 
distribution (a priori cutoff of p < 0.05). Based on -2LL test results during model building, 
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random intercepts and slopes were included for each woman. Random intercepts allow 
each woman to differ in her level of the outcome; random slopes allow the outcome to 
change differently over gestation for each woman 
Next, we used a backward elimination approach to examine effect measure 
modification (EMM) and confounding. We conducted -2LL tests to evaluate the 
contribution of product interaction terms for malaria and potential EMMs on mean 
differences in UtA RI and UA RI (ML estimation; a priori cutoff of p < 0.10). If a 
hypothesized modifier was not identified as an EMM, it was assessed as a potential 
confounder. Potential confounders were identified through a review of the literature and 
through analysis via a Directed Acyclic Graph (DAG) for the model (Greenland, Pearl et 
al. 1999; Rothman, Greenland et al. 2008). Covariates were considered confounders 
and retained in the model if the change in the DAG model mean estimate was greater 
than 10% within strata of EMMs (Rothman, Greenland et al. 2008).  
Finally, we estimated model effects using restricted maximum likelihood (REML), 
as ML estimation can result in biased random effect estimates in small samples 
(Fitzmaurice 2009). We verified model assumptions by conducting a residual and 
iterative influence analyses. Model outputs include fixed effect parameters, which 
quantify the effects of predictors on the population average change trajectories, and 
random effect parameters, which assess the variability at the two levels across different 
subjects. The regression coefficient for malaria in the proposed linear mixed model can 
be interpreted as the difference in the outcome between women with and without 
malaria. Following the specification of the final model, we examined the unadjusted 
effect of malaria on the outcomes. We plotted population average growth curves to 
describe the unadjusted and adjusted effect of malaria on uteroplacental blood flow. All 
analyses were performed using SAS software (SAS, Cary, NC). 
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Sensitivity analyses 
We performed simple sensitivity analyses to examine the robustness of model 
estimates to changes in the definition of our outcome and in our time metric, ultrasound 
estimated gestational age.  
We examined the difference in weeks between last menstrual period and ultrasound 
estimates of gestational age (last menstrual period estimated gestational age – 
ultrasound estimated gestational age). We report the mean and standard deviation for 
the calculated difference in gestational age difference. As bias in ultrasound dating may 
be introduced if a fetus is larger or smaller for gestational age than expected, we 
examined the mean differences in gestational age dates across strata of maternal and 
fetal characteristics from our multivariable models known or theorized to be associated 
smaller fetuses (including malaria parasitemia at dating ultrasound; gravidity; fetal sex; 
and low maternal MUAC at baseline). Finally, we examined robustness of the UtA RI 
and UA RI final models to changes in the time-metric, ultrasound estimated gestational 
age in two sensitivity analyses in which we reran the final models using last menstrual 
period dating (S1); and, among the subset of women with ‘certain’ gestational age (i.e. 
LMP within ±14 days of the ultrasound derived date) (S2).  
For the uterine artery resistance outcome, we conducted a third sensitivity analyses 
in which we examined the effect of using the resistance index value from the highest 
uterine artery rather than the mean value of the left and right uterine arteries (S3). 
Results for sensitivity analyses can be found in Appendix 1. 
Specific Aim 2 Analyses 
Using longitudinal Doppler ultrasound cohort data, Aim 2A estimated the effect of 
malaria in early pregnancy on subsequent uterine artery and umbilical artery resistance 
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indices over time. Aim 2B estimated the effect of malaria in early pregnancy on the 
subsequent risk of intrauterine growth restriction. For Aim 2, we left-truncated person-
time data at 21 weeks’ gestation, resulting in 548 visits with Doppler ultrasound and fetal 
biometric measurements (Figure 3.4). We examined IUGR after 20 weeks’ gestation for 
three main reasons: 1) we were interested in examining the “chronic” effects of early 
pregnancy malaria exposure for the duration of pregnancy; 2) we had very few Doppler 
ultrasound data points prior to 21 weeks’ gestation as uterine artery and umbilical artery 
blood flow were not measured at the baseline study visit; and 3) there is little variation in 
fetal weight through the first trimester and IUGR is often not seen until the second 
trimester. 
Study population 
For this, we excluded 5 HIV-positive participants and 49 participants with no 
malaria exposure data ≤ 20 weeks’ gestation, leaving an analytic sample of 128 women, 
with 548 antenatal visits after 20 weeks’ gestation that included fetal biometric measures 
and interrogation of uterine and umbilical blood flow. Excluded participants did not 
significantly differ from those women enrolled later in pregnancy in age, gravidity, fetal 
sex, or socioeconomic status (SES), but were more likely to have a low level of 
education and to be undernourished (data not shown). Participants in the analytical 
sample were enrolled at a median of 18 weeks’ gestation (interquartile range [IQR]: 16, 
19) and were followed up for a median of 19 weeks (IQR: 17, 21). Study participants had 
a median of 7 follow-up visits (IQR: 6, 8), with 5 ultrasound scans (IQR: 4, 5) from 
enrollment to delivery.  
Variables 
Exposure: 
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Early pregnancy malaria: The primary malaria exposure variable was based on 
real-time quantitative (q)PCR for P. falciparum malaria from peripheral dried blood 
samples. The exposure variable, ‘early pregnancy malaria,’ was a binary, time-
independent measure representing whether a woman was ever qPCR positive for 
peripheral P. falciparum malaria parasitemia at ≤20 weeks’ gestation. Early pregnancy 
malaria was treated dichotomously: 0 (no early pregnancy malaria) and 1 (early 
pregnancy malaria).  
Outcomes: 
Uterine artery resistance index and umbilical artery resistance index were 
defined as described in Aim 1. In addition, we examined subsequent intrauterine growth 
restriction. 
Intrauterine growth restriction: IUGR was defined as a time-varying binary 
outcome of <10th percentile of SEFW for attained gestational age using the longitudinally 
derived sex-specific Johnsen fetal standard curve (Johnsen, Rasmussen et al. 2006). 
IUGR was coded as yes (1) or no (0) at each ultrasound visit. SEFW in grams, was 
calculated according to the Hadlock algorithm: log(EFW)=1.3596 - 0.00386*AC*FL + 
0.0064*HC + 0.00061*BPD*AC + 0.0424*AC + 0.174*FL (Hadlock, Harrist et al. 1985). 
Hadlock’s formula is among those with the highest accuracy and precision in several 
recent reviews of the algorithms for estimated fetal weight (Kurmanavicius, Burkhardt et 
al. 2004; Dudley 2005; Anderson, Jolley et al. 2007). At each visit, women were 
classified as having an IUGR episode if, at that visit, their fetus was <10th percentile of 
SEFW for gestational age in completed weeks, using the longitudinal, sex-specific 
Johnsen SEFW nomogram (Johnsen, Rasmussen et al. 2006). We also examined 
repeated episodes of sonographically-identified IUGR. “Repeat IUGR” was a binary, 
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time-dependent outcome defined as IUGR (as previously defined), with ≥ 2 total IUGR 
episodes during pregnancy.  
Time metric: 
As in Aim 1, the continuous time metric, gestational age in weeks, was back-
calculated from the first ultrasound using Hadlock’s algorithm (Hadlock, Deter et al. 
1984). 
Effect measure modifiers: 
Hypothesized effect measure modifiers were the same as those described in Aim 
1. 
Covariates:  
Covariates assessed as potential confounders in the models were identical to 
Aim 1.  
Data analysis 
The data analysis plan for Specific Aim 2 was identical to the plan for Specific 
Aim 1 for continuous variables. As in Aim 1, we utilized linear mixed-effect models. Here, 
LME models were used to estimate the effect of early pregnancy malaria on UtA RI and 
UA RI. However, for Aim 2, we utilized a log-binomial generalized estimating equation 
(GEE) regression model (Liang and Zeger 1986) with an exchangeable correlation 
matrix for the binary outcome, intrauterine growth restriction. We estimated the 
unadjusted and adjusted risk ratios for IUGR with corresponding 95% confidence 
intervals. Like LME models, GEE models are appropriate for repeated measures 
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outcomes as they account for correlation between repeated measures (Liang and Zeger 
1986).  
For the log-binomial GEE model for IUGR, we began with crude models 
separately fitted for the early pregnancy malaria exposure variable and theorized effect 
measure modifiers. Next, we constructed simple log-binomial models with early 
pregnancy malaria, a theorized modifier, and their product interaction term. We 
examined risk ratios for the effect of early pregnancy malaria on IUGR within strata of 
the modifying variable. If the product interaction term was significant using the Wald test 
(a priori cut-off of 0.10), it was considered an effect measure modifier and was included 
in a multivariable model. 
Multivariable model building occurred in several steps. We began with a fully 
adjusted log-binomial model, including the early pregnancy malaria exposure, the 
exposure modifier product interaction terms and covariates that were DAG confounders 
of the association between malaria and IUGR. Potential confounders were identified 
through a review of the literature and through analysis via a DAG for the model 
(Greenland, Pearl et al. 1999; Rothman, Greenland et al. 2008), and included maternal 
age, socioeconomic status, and education level (Figure 3.5). EMMs that were not found 
to modify the exposure outcome were evaluated as confounders. Covariates were 
considered confounders and not retained in the model if the change in the DAG model 
risk ratio was <10% within strata of EMMs (Rothman, Greenland et al. 2008).  
Finally, we estimated the adjusted risk ratios. We reported the unadjusted and 
adjusted risk ratios for the effect of early pregnancy malaria on IUGR with corresponding 
95% confidence intervals. The risk ratios for the final model can be interpreted as the 
risk of IUGR in women with early pregnancy malaria compared to women without early 
pregnancy malaria. All analyses were performed using SAS software (SAS, Cary, NC). 
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Sensitivity analyses 
We performed sensitivity analyses to examine the robustness of model estimates to 
changes in model parameters. Results for all sensitivity analyses can be found in 
Appendix 2. In our first set of sensitivity analyses for LME models, we determined the 
robustness of model estimates to the definition of our time metric, ultrasound estimated 
gestational age. For all LME models, we examined the effect of using LMP estimated 
gestational age (S1) and we restricted the analysis to the subset of women with ‘certain’ 
gestational age (i.e. LMP within ±14 days of the ultrasound derived date) (n=145, with 
608 study visits) (S2). For the uterine artery resistance LME model, we examined using 
the highest resistance index of the two uterine arteries as our outcome variable (S3). We 
also examined the use of a previously recommended cut-offs for maternal under nutrition 
(i.e. baseline MUAC <23 cm (S4)). Sensitivity analyses for umbilical artery resistance 
and uterine artery resistance can be found in Figures A2.1 and 2.2, respectively.  
For the estimation of sonographically estimated fetal weight, we examined how 
robust our models were to changes to the algorithm for sonographically estimated fetal 
weight. We examined the association between early pregnancy malaria and SEFW 
estimated by algorithms developed by Combs (Combs, Jaekle et al. 1993) and Woo 
(Woo, Wan et al. 1985). Changes to the algorithms gave different estimates for SEFW, 
but did not have a noteworthy effect on LME model estimates for the effect of early 
pregnancy malaria on EFW (data not shown). 
To determine how robust our IUGR findings were to our choice of fetal standard 
curve, we examined the use of two additional ultrasound-derived fetal standard curves in 
a sensitivity analyses. First, we considered Hadlock’s fetal standard curve (Hadlock, 
Harrist et al. 1985). Hadlock’s curve provides good fit to Project ECHO data at the 10th 
percentile (Landis 2007); is not sex-specific; and, was previously used in an analysis of 
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IUGR in Project ECHO data (Landis, Lokomba et al. 2009). We also considered 
Gallivan’s fetal standard curve. Gallivan’s curve is prospective and is not sex-specific 
(Gallivan, Robson et al. 1993). Results for sensitivity analyses for early pregnancy 
malaria and IUGR can be seen in Appendix 2, Figure A2.3. Characteristics of the fetal 
standard curves utilized can be seen in Appendix 2, Table A2.1. 
Approach to Missing Data 
Missing data and loss to follow-up were minimal in Project ECHO. Study 
protocols were in place should a woman miss a scheduled appointment or deliver in a 
different hospital. Two women were lost to follow-up during the study, including one 
maternal death and one woman who moved out of the study area. Of 182 women, 
delivery data are missing for one maternal death and for one woman who completed all 
study visits, but couldn’t be located for delivery (1% or 2/182). There are partial delivery 
data for 10 women (6% or 10/180) who did not delivery at Binza Maternity Hospital, with 
no infant size measurements. The proportion of missing data for predictors ranges from 
0% for time-invariant measurements to <1% for fetal biometric measurements to 
approximately 6% for uterine artery Doppler measures. The probability of missingness in 
Project ECHO data is likely unrelated to unobserved concurrent outcomes (UtA RI, UA 
RI, SEFW and IUGR), conditional on all observed outcomes. Thus, we expect Project 
ECHO data to adhere to the “missing at random” (MAR) assumption for Aims 1 and 2, 
providing unbiased results, and negligible losses in precision. In LME models (Aims 1 & 
2), model estimates have been shown to be relatively robust to small deviations from the 
assumption of MAR (Singer and Willett 2003). For the binary outcome variable IUGR 
(Aim 2), the very low level of missing data (<1%) is unlikely to significantly bias study 
results. 
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Strengths and Limitations 
Project ECHO data uniquely provide the ability to examine several critical gaps in 
the field of malaria and pregnancy, namely, the relationship between the timing of 
malaria episodes and both placental circulations and in utero fetal size. However, there 
are several factors that limit the validity or generalizability of these data. These analyses 
focus on women in urban Kinshasa, receiving antenatal care, and enrolled in a 
prospective cohort. Enrolled women received two doses of IPT and were treated at 
monthly or interim visits for malaria. Thus, our findings may not be directly applicable to 
rural women receiving lower levels of antenatal care; who do not receive IPT; and, who 
are not actively diagnosed and treated for malaria infection. There were several 
unmeasured variables that may confound the relationship between malaria and study 
outcomes, including: time elapsed between pregnancy for multigravidae and possibly 
sickle-cell trait. Additionally, accurate measures of maternal weight were not available for 
all time points, so our ability to use maternal weight as a time-varying covariate was 
limited.  
There may be important systematic and random error in estimates of gestational 
age and fetal weight. While bias and random error are inherent in regression equations, 
we have attempted to select commonly used formulae, with low levels of bias and high 
levels of precision. We utilized a longitudinally derived fetal growth curve from an 
industrialized country setting that distinguished between fetal genders for the 
identification of IUGR. The selection of an appropriate nomogram can affect the 
proportion of IUGR fetuses identified in a population (Appendix 2, Table 2.1). As such, 
we felt a sensitivity analysis of study findings using a different fetal growth curves would 
be useful. 
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We had limited power to detect differences. This study was initially designed as a 
pilot study to prepare laboratory, ultrasound and clinical operating procedures for a 
larger subsequent trial. Thus the sample size was selected for convenience, rather than 
to maximize power. Power may be particularly limited for the analyses of binary 
outcomes (Specific Aim 2). However, by coding outcome variables continuously for Aims 
1 & 2, we attempted to increase power to detect reasonably small differences. 
There are also important strengths of these data, including the prospective 
nature of the data, by which we have the ability to infer causality to our findings. We had 
reasonable reliable and precise estimates of gestational age, which have historically 
been a challenge in malaria endemic areas. Most critically to our analyses, we have 
prospective serial measures of Doppler fetal biometrics and EFW; blood flow velocity 
waveforms; and incident malaria parasitemia. While qPCR is considered a highly 
sensitive method to identify malaria, the test characteristics of qPCR have not been 
compared to the gold standard of placental histology. Positive qPCR malaria results that 
were discordant from microscopy were rerun; methods were used to prevent and detect 
contamination issues. Finally, we had very low levels of missing data.
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Figure 3.1 Recruitment results for longitudinal Doppler ultrasound study. Kinshasa, 
Democratic Republic of Congo, 2005-2006 
 
1,111 pregnant women present for 
first antenatal care at Binza 
370 meet pre-eligibility criteria and 
consent to ultrasound examination for 
confirmation of gestational age 
24 absent for ultrasound 
examination  
346 present for ultrasound 
determination of gestational age 
164 not eligible (154 GA >22 
weeks, 0 days; 6 multiple 
gestations; 4 non-viable fetuses) 
182 eligible women provide written 
informed consent and are enrolled 
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Figure 3.2 Results of follow-up and delivery for longitudinal Doppler ultrasound study. 
Kinshasa, Democratic Republic of Congo, 2005-2006. 
 
Baseline visit (N=182) 
1 maternal death; 1 loss to follow-up  Follow-up visit 1 (N=182) 
Follow-up visit 2 (N=180) 10 term births; 4 preterm deliveries; 3 
preterm / stillbirth; 1 preterm / neonatal 
death; 1 loss to follow-up Follow-up visit 3 (N=180) 
Follow-up visit 4 (N=161) 85 term births; 2 preterm deliveries 
Follow-up visit 5 (N=74) 54 term births; 1 preterm delivery 
Follow-up visit 6 (N=19) 18 term births; 1 preterm delivery 
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Table 3.1 Summary of ultrasound, clinical and laboratory measurements. Democratic 
Republic of Congo, 2005-2006. From (Landis 2007)
Visit Measurements 
Baseline 
 
Clinical history 
Sociodemographics 
Last menstrual period 
HIV testing and counseling 
Ultrasound examination  
Fundal height 
Peripheral parasitemia and 
assessment for fever 
Filter paper sample 
1st dose of intermittent 
preventive treatment 
Height, weight, mid-upper arm 
circumference 
BP, pulse 
Hematocrit 
Urine test 
Assessment for edema 
Follow-up 
(monthly) 
Ultrasound examination  
Fundal height 
Peripheral parasitemia and 
assessment for fever 
Filter paper sample  
2nd dose of intermittent 
preventive treatment 
Weight, mid-upper arm 
circumference 
BP/pulse 
Hematocrita 
Urine test 
Assessment for edema 
Delivery Women: 
Peripheral parasitemia 
Filter paper sample  
Placental biopsy  
Hematocrit test 
Maternal mortality 
Infants: 
Birth weight 
Length (crown-heel, crown-
rump) 
Head circumference  
Abdominal circumference 
Gestational age  
Infant mortality 
a. Hematocrit tests were performed at every other follow-up visit 
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Figure 3.3 Simplified directed acyclic graph for malaria and uterine artery resistance 
index (UtA RI) and umbilical artery resistance index (UA RI) (Aim 1). 
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Figure 3.4 Timeline for key pregnancy events and study variables. Black arrow denotes 
gestational age in weeks. The temporal relationships between key events during 
pregnancy and peak malaria prevalence are shown (above black arrow). The temporal 
relationships between early pregnancy malaria exposure, subsequent placental blood 
flow and fetal growth outcomes, and typical IPTp dosing are shown (below black 
arrow).
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Figure 3.5 Simplified directed acyclic graph for malaria and fetal growth outcomes, 
estimated fetal weight and intrauterine growth restriction (Aim 2). 
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CHAPTER 4 - MALARIA IN PREGNANCY AND UTERO- AND FETOPLACENTAL 
BLOOD FLOW: GRAVIDITY AND FETAL SEX-SPECIFIC EFFECTS 
Abstract 
Malaria during pregnancy leads to low birth weight, possibly due to reduced uterine and 
umbilical artery blood flow. The relationship between malaria and uterine and umbilical 
artery blood flow has not been examined longitudinally. Malaria parasitemia was 
measured and Doppler ultrasound interrogated uterine and umbilical artery resistance at 
monthly antenatal care visits for 177 pregnant women from Democratic Republic of 
Congo. Women ever having high uterine artery or high umbilical artery resistance had 
smaller infants at delivery. Malaria reduced both uterine and umbilical artery blood flow. 
Compared to multigravidae with no malaria, primigravidae with malaria had an 11-13% 
increase in uterine artery resistance. The effect of malaria on fetoplacental blood flow 
was sex-specific. Compared to women with no malaria and a male fetus, women with 
malaria and a female fetus had a 10-14% increase in umbilical artery resistance, while 
women with malaria and a male fetus had a 2-3% increase. Reduced blood flow is a 
likely mechanism by which malaria leads to intrauterine growth restriction. The effects of 
malaria on fetoplacental blood flow are sex-specific, possibly via sex-specific placental 
cytokine responses to malaria parasitemia. 
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Introduction 
From a public health perspective, Plasmodium falciparum malaria in pregnancy is 
among the most important preventable causes of low birth weight in sub-Saharan Africa 
(Kramer 1987; Steketee, Nahlen et al. 2001; Guyatt and Snow 2004). While there are 
multiple mechanisms by which malaria in pregnancy leads to low birth weight (Rogerson, 
Hviid et al. 2007), one is thought to be the reduction of utero- and fetoplacental blood 
flow (Arbeille, Carles et al. 1998; Dorman, Shulman et al. 2002). 
Uterine artery blood flow (from the mother to the placenta) and umbilical artery 
blood flow (from the fetus to the placenta) increase over pregnancy to meet the 
metabolic demands of the growing fetus. Pathophysiological events in the placenta can 
decrease blood flow in the uterine or umbilical arteries, leading to a reduced capacity to 
transport oxygen and nutrients and, ultimately, to restricted fetal growth. Malaria in 
pregnancy has previously been found to be associated with abnormal utero- and 
fetoplacental circulation in the late second and early third trimesters (Arbeille, Carles et 
al. 1998; Dorman, Shulman et al. 2002).  
Doppler assessment of the uterine and umbilical arteries allows for the non-
invasive evaluation of blood flow and resistance in the maternal and fetal compartments 
of the placenta, respectively. Increased uterine artery resistance is associated with 
preeclampsia, restricted fetal growth and adverse pregnancy outcomes (Trudinger, Giles 
et al. 1985; Irion, Massé et al. 1998), while increased umbilical artery resistance is 
associated with fetal distress and restricted fetal growth (Giles, Trudinger et al. 1985; 
Trudinger, Giles et al. 1985). 
To date, the effect of malaria on utero- and fetoplacental blood flow and 
resistance has not been examined longitudinally over pregnancy. The objective of this 
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longitudinal analysis was to examine the effect of malaria parasitemia on changes in the 
uterine artery (UtA) and umbilical artery (UA) resistance indices (RI) over time. 
Methods 
Study population 
From May 2005 to May 2006, pregnant women seeking antenatal care at Binza 
Maternity Hospital were screened for pre-eligibility (n=1,111). One-third (n=370) met pre-
eligibility requirements (≥ 18 years of age; not hypertensive; and <23 weeks’ gestation 
by last menstrual period dating). Pre-eligible women had gestational age estimated via 
ultrasound (Hadlock, Deter et al. 1984) within 3-5 days of pre-eligibility screening to 
determine study eligibility. Of these, 182 women met screening criteria (healthy, 
singleton pregnancy ≤22 weeks’ gestation by ultrasound dating); provided written 
informed consent; and were enrolled in the study. Enrolled women received intermittent 
preventive therapy with sulfadoxine-pyrimethamine twice (between 16-27 and 28-32 
weeks) and an insecticide treated bed net. Five HIV-positive women were excluded from 
the analysis, leaving a final sample of 177 women, with a total of 1120 antenatal visits. 
Participants had a median of 6 visits (interquartile range:  5, 7) and 4 ultrasound scans 
(interquartile range: 4, 5).  
This study was approved by the Institutional Review Boards of the University of 
North Carolina at Chapel Hill and the Kinshasa School of Public Health. 
Clinical, Laboratory and Ultrasound Procedures 
Data were collected at baseline in a socio-demographic interview; a medical 
examination (maternal anthropometrics, blood pressure, pulse, temperature); an 
ultrasound examination (estimation of gestational age and fetal weight); and laboratory 
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testing (urine protein, hematocrit, malaria thick and thin smears, and filter paper dried 
blood spot samples) as previously described (Landis, Lokomba et al. 2009). At follow-up 
visits, ultrasound examinations and medical and laboratory examinations (including 
malaria thick and thin smears and filter paper dried blood spot samples) were repeated. 
Gestational age and fetal biometrics were measured using standard procedures as 
previously described (Landis, Lokomba et al. 2009). Quantitative real-time polymerase 
chain reaction (qPCR) was conducted to detect all Plasmodium species from dried blood 
spot samples and positive samples were speciated as previously described (Taylor, 
Juliano et al. 2010). 
Color pulsed-wave Doppler ultrasound was used to interrogate the flow velocity 
waveforms in the left and right UtAs and the UA using standard techniques. The external 
iliac artery and UtA located medial to it were identified using color flow settings. Flow 
velocity waveforms were obtained from the UtA near the iliac vessel prior to division of 
the UtA into branches. For left and right UtA analyses, Doppler indices were measured 
from the Doppler signal, with qualitative assessment of early diastolic notching. For the 
UA, the flow velocity waveform was obtained from the free flowing portion of the 
umbilical cord and Doppler indices and presence of absent or reversed end-diastolic flow 
were recorded. All ultrasound measurements were taken by a single, trained 
obstetrician-gynecologist (V.L.) on the GE Logicbook Ultrasound System. 
Variable definitions 
The malaria exposure was a binary, time-dependent measure representing 
whether a woman was qPCR positive for Plasmodium falciparum malaria at the visit in 
which Doppler measures were taken. We utilized qPCR of peripheral dried blood spots 
rather than blood microscopy due to the higher detection threshold of microscopy and 
the potential for poor microscopy sensitivity and specificity (Ohrt, Obare et al. 2007). In a 
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secondary analysis, we examined a categorical, time-dependent malaria exposure 
comparing microscopic (microscopy positive, qPCR positive) and submicroscopic 
(microscopy negative, qPCR positive) malaria to women with no parasitemia at the visit 
in which Doppler measures were taken. 
Outcome variables included the continuous, time-dependent mean of the left and 
right UtA RI and the UA RI.  Commonly used Doppler indices include the resistance 
index, the pulsatility index and the S/D ratio. We selected the resistance index for our 
outcome for several reasons: RI values are constrained between 0 and 1; demonstrate 
the least variance of the Doppler indices under identical hemodynamic conditions; are 
frequently used in clinical settings; and have a truncated normal distribution, making the 
RI amenable to parametric statistical analyses (Maulik 2005). The RI is defined as: (peak 
systolic velocity – end diastolic velocity) / peak systolic velocity. We also examined the 
time-dependent, binary outcome unilateral UtA notching after 20 weeks’ gestation. Early 
diastolic notching is normal in early pregnancy, but in later pregnancy reflects extreme 
resistance to uterine artery flow.  
The time metric, gestational age in weeks, was back-calculated from the first 
ultrasound using Hadlock’s formula (Hadlock, Deter et al. 1984). 
Hypothesized effect measure modifiers were binary, time-independent variables 
and included: primigravidae (vs multigravidae); female fetal sex (vs male); and low 
baseline mid-upper arm circumference (MUAC) (vs ‘normal’ MUAC). MUAC is an 
indicator of maternal nutritional status that is relatively unaffected by gestational age and 
is a proxy for pre-pregnancy weight (Krasovec and Anderson 1991). Women with 
baseline MUAC in the lowest quartile (<24.5 cm) were classified as ‘Low MUAC.’ 
Potential confounders were identified in the literature and analyzed via a directed acyclic 
graph. Confounders included maternal age (18-24, ≥30 years vs. 25-29 years), 
education level (<secondary vs. ≥secondary); and socioeconomic status (SES) (low vs. 
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high). ‘Low SES’ was defined as a binary composite variable, with women meeting all of 
the following criteria categorized as ‘low SES’: currently unemployed, living in a home 
without toilet facilities, no access to a nearby water source, and no electricity. 
We also examined UtA RI and UA RI as binary, time-independent predictors of 
perinatal outcomes, in which women who ever experienced UtA RI or UA RI >90th 
percentile for gestational age were defined as ‘ever high’ UtA RI or UA RI, respectively 
(Merz and Bahlmann 2005). We examined the time-independent binary outcomes LBW 
(<2500 grams), small for gestational age (<10th centile of Wilcox standard curve for 
attained gestational age) (Wilcox, Gardosi et al. 1993), and preterm (<37 weeks’ 
gestation). We examined the continuous, time-independent outcomes: gestational age at 
delivery (days), birthweight (grams), head circumference (cm), abdominal circumference 
(cm), and crown-rump length (cm), which were measured using standard techniques, as 
previously described (Landis 2007). 
Statistical analyses 
We described the baseline characteristics of study population and fitted linear 
mixed effect (LME) models to estimate simple mean differences and corresponding 95% 
confidence intervals (CIs) in UtA RI and UA RI for covariates, adjusting for gestational 
age (Laird and Ware 1982). We explored the change of UtA RI and UA RI over time by 
plotting individual growth trajectories with population average smoothed trend line. We 
utilized LME models to estimate the unadjusted and adjusted mean differences in UtA RI 
and UA RI with corresponding 95% CIs. LME models are flexible regression tools that 
account for the correlation between repeated measures in an individual (Laird and Ware 
1982). We plotted population average growth curves to describe the unadjusted and 
adjusted effect of malaria on utero- and fetoplacental blood flow. We estimated 
unadjusted risk ratios (RRs) and 95% CIs for binary perinatal outcomes using log-
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binomial regression and estimated unadjusted mean differences and 95% CIs for 
continuous perinatal outcomes using linear regression. 
For multivariable modeling of the effect of malaria on UtA RI and UA RI, we 
began with a fully adjusted LME model with a random intercept. Linearity between 
gestational age and the outcome variables was considering by using -2 log-likelihood (-
2LL) tests for nested models using maximum likelihood estimation (a priori cutoff of P < 
0.10). We tested the addition of additional random effects using -2LL tests with a mixed 
chi-square distribution (a priori cutoff of P < 0.05). In the final model we included random 
intercepts and slopes for each woman. We used backward elimination to assess effect 
measure modification and confounding. We used -2LL tests to evaluate the contribution 
of product interaction terms for malaria and potential modifiers (gestational age, 
gravidity, fetal sex, and maternal MUAC) to the models (a priori cutoff of P < 0.10). 
Potential modifiers that did not modify the association between malaria and the outcome 
were assessed as potential confounders. Covariates were considered confounders if the 
change in the coefficient of the main exposure was greater than 10%, within strata of 
modifiers. Restricted maximum likelihood was used for final model estimates, as is 
common practice (Fitzmaurice 2009). Following the specification of the final model, we 
examined the unadjusted effect of malaria on the outcomes. All analyses were 
performed using SAS software (SAS, Cary, NC). 
Results 
Maternal characteristics and uteroplacental blood flow (Table 4.1) 
The median age of the 177 pregnant women was 27 years (interquartile range: 
23, 31) and approximately one-quarter of participants were primigravidae. Greater than 
half of pregnancies were with a female fetus. Most women had low socioeconomic 
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status (86%), and half had a low level of education. One-quarter of women met our 
definition as having a low MUAC. Uterine artery resistance was elevated in women 30 
years of age and older and in women with a female fetus. Umbilical artery resistance 
was elevated in primigravidae, women with a female fetus, and women with a low level 
of education. 
The 177 women were enrolled at a median gestational age of 19 weeks 
(interquartile range: 16, 21) and were followed for a median of 18 weeks’ (interquartile 
range: 16, 20). During this time, thirty percent of women had malaria parasitemia, with 
the prevalence of parasitemia falling during pregnancy from 20% during the early second 
trimester to 8% during the late third trimester. Fewer than 10% (93/1105) of antenatal 
visits were positive for malaria parasitemia. Women with less than a secondary level of 
education had an increased risk of ever having malaria parasitemia during follow-up (risk 
ratio [RR]: 1.7; 95% CI: 1.0, 2.7) compared to women with a secondary level of 
education or higher. Maternal age, gravidity, fetal sex, low SES, and having low MUAC 
at baseline were not significantly associated with risk of ever having malaria parasitemia 
during follow-up. 
Utero- and fetoplacental blood flow (Figure 4.1) 
We plotted individual trajectories of the continuous outcomes, UtA RI and UA RI, 
in order to examine the intra- and inter-subject variability over gestational age (Figure 
4.1). The steeper negative change in UtA RI until approximately 26 weeks’ gestation 
(Panel A) reflects trophoblast invasion and remodeling of the spiral arterioles. After 20 
weeks’ gestation, there were 13 episodes of unilateral notching and 2 episodes of 
bilateral notching of the uterine arteries among 12 women. UA RI began higher and had 
a steeper downward slope over the course of pregnancy (Panel B), due to angiogenesis 
in the villous structure of the placenta. In the most extreme cases, absent or reversed 
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end-diastolic flow may be seen in the umbilical artery. This phenomenon was uncommon 
in this cohort, with 4 episodes occurring after 20 weeks’ gestation. 
High utero- and fetoplacental blood and perinatal outcomes (Table 4.2) 
Forty-one percent of women ever had a high UtA RI and 41% ever had a high UA 
RI. UtA RI and UA RI were not strongly associated (Prevalence ratio: 1.2; 95% CI: 0.9, 
1.8). Women with high UtA RI or UA RI had neonates with increased risk of small for 
gestational age, while neonates with high UA RI were also had increased risk of low birth 
weight, although this finding was not statistically significant. Compared to neonates with 
normal UtA RI, neonates with high UtA RI were smaller, with decreased birth weight, 
crown-rump length and abdominal circumference. There was also a trend toward 
decreased head circumference. Neonates with high UA RI had decreased birth weight, 
decreased abdominal circumference and crown-rump length. There was no association 
between high UA RI and head circumference. Neither gestational age at delivery nor 
preterm delivery was associated with high Doppler indices. 
Malaria and uteroplacental blood flow (Figure 4.2) 
There was no crude effect of malaria on uterine artery resistance. However, in 
the adjusted model, the effect of malaria on UtA RI varied by gravidity. Compared to the 
referent group of multigravidae with no malaria, the mean difference in UtA RI for 
malaria was -0.0073 (95% CI: -0.033, 0.018) and for primigravidae was -0.0034 (95% CI: 
-0.028, 0.021). The joint effect of malaria and primigravidae was 0.063 (95% CI: -0.0088, 
0.13), or approximately 0.7 standard deviations. In other words, compared to the referent 
group, malaria increased UtA RI by 11-13% among primigravidae, but malaria did not 
increase UtA RI among multigravidae. We did not find a crude association between 
malaria and uterine artery notching after 20 weeks’ gestation (p = 0.9), though this has 
71 
 
been previously reported in primigravidae (Dorman, Shulman et al. 2002). Fetal sex and 
maternal nutritional status did not modify the relationship between malaria and UtA RI. 
Malaria and fetoplacental blood flow (Figure 4.3) 
In the unadjusted model, malaria caused a 0.032 increase in UA RI (95% CI: 
0.010, 0.055), compared to the referent of no malaria. In the adjusted model, the effect 
of malaria on UA RI was found to vary by fetal sex. Compared to the referent group of 
male fetuses with no malaria, the mean difference in UA RI for malaria was 0.016 (95% 
CI: -0.019, 0.050) and for female fetal sex was 0.021 (95% CI: 0.0065, 0.035). The joint 
mean difference in UA RI for women with current malaria and a female fetus was 0.076 
(95% CI: 0.044, 0.11), or approximately four-fifths of a standard deviation. These 
findings signify a 10-14% increase in UA RI among women with malaria and a female 
fetus, and a 2-3% increase in UA RI among women with malaria and a male fetus, 
compared to the referent group of women with no malaria and a male fetus. We did not 
find that gravidity or maternal nutritional status modified the relationship between malaria 
and UA RI. 
 
Discussion 
In this longitudinal, pulsed-wave Doppler study, we report that malaria decreases 
utero- and fetoplacental blood flow. To our knowledge, our results are the first to identify 
that fetal sex modifies the pathological effects of malaria in pregnancy, with malaria 
significantly increasing umbilical artery resistance among female fetuses only. As 
expected (Giles, Trudinger et al. 1985; Trudinger, Giles et al. 1985; Irion, Massé et al. 
1998), high UtA RI and UA RI were associated with decreases in fetal growth.  
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Malaria caused an acute increase in uterine artery resistance among 
primigravidae, as previously reported (Dorman, Shulman et al. 2002). We did not find 
increased uterine artery resistance among multigravidae. This is consistent with 
observations showing worse malaria-associated birth outcomes among primigravidae in 
areas of stable transmission (Desai, ter Kuile et al. 2007). Uterine artery blood flow to 
the placenta could be slowed by infected erythrocytes and inflammatory infiltrates in the 
intervillous spaces of the placenta, which can be massive, especially among 
primigravidae (Ordi, Ismail et al. 1998; Ordi, Menendez et al. 2001). In our cohort, 
microscopic, but not submicroscopic, parasitemia was associated with increased uterine 
artery resistance among primigravidae. Peripheral parasitemia detectable by microscopy 
has been found to be associated with higher densities of placental infection 
(Mockenhaupt, Ulmen et al. 2002). Together these findings suggest that mechanical 
obstruction of blood flow via the accumulation of infected erythrocytes and inflammatory 
infiltrates in the intervillous spaces of the placenta leads to increased uterine artery 
resistance. 
We report that the pathological effects of malaria during pregnancy are modified 
by fetal sex, with malaria significantly increasing umbilical artery resistance among 
female fetuses only. Studies of malaria in pregnancy from the 1960s noted an increased 
prevalence of placental malaria in female fetuses (McLaren and Ward 1962; Jelliffe 
1968), although this direction of research appears to have been abandoned. Today, 
there is growing evidence for sex-specific adaptive mechanisms in adverse placental 
environments, such as maternal asthma (Murphy, Gibson et al. 2003; Scott, Hodyl et al. 
2009), pre-eclampsia (Stark, Dierkx et al. 2006; Stark, Clifton et al. 2009), and preterm 
delivery (Stark, Clifton et al. 2008).  
Malaria during pregnancy may produce differential effects on fetoplacental blood 
flow via sex-specific immune responses, such as increased inflammatory responses 
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among female fetuses (Scott, Hodyl et al. 2009). During placental malaria, there is 
increased expression of pro-inflammatory cytokines such as tumor necrosis factor 
(TNF)-α and interleukin (IL)-8, which are also associated with low birth weight (Fried, 
Muga et al. 1998; Moormann, Sullivan et al. 1999; Abrams, Brown et al. 2003). IL-8 is 
associated with decreased umbilical artery blood flow (Trudinger, Wang et al. 2002; 
Wang, Athayde et al. 2003) and has been shown to be expressed  in greater 
concentrations (in addition to other pro-inflammatory cytokines) in female placentas 
compared to male placentas with asthma (Scott, Hodyl et al. 2009). There may also be 
sex-specific responses along the hypothalamic-pituitary-adrenal axis and/or the insulin-
like growth factor (IGF) axis, both previously shown to be associated with placental 
malaria (Umbers, Boeuf et al. ; Bouyou-Akotet, Kombila et al. 2004). Compared to male 
fetuses in pregnancies complicated by asthma, female fetuses have decreased growth, 
with increased cortisol levels and decreased cortisol metabolism (Stark, Wright et al. 
2009). Female fetuses exposed to maternal asthma and cigarette use have decreased 
IGF-1, while males fetuses exposed to maternal asthma have increased IGF-1 (Clifton, 
Hodyl et al.). More research is needed to understand the modifying role of fetal sex in 
the pathology of placental malaria. 
The antenatal diagnosis of placental malaria is problematic as the assessment of 
placental malaria is unavailable prior to delivery and placental infection can occur in the 
absence of peripheral infection (Rogerson, Chaluluka et al. 2000). At delivery, PCR has 
been found to be highly sensitive for placental malaria identified by blood smear 
microscopy (Malhotra, Dent et al. 2005; Mockenhaupt, Bedu-Addo et al. 2006); however, 
specificity may be lower (Mockenhaupt, Ulmen et al. 2002). To date, evidence regarding 
the clinical relevance of submicroscopic infections has been inconsistent, with 
submicroscopic infections predictive of poor birth outcomes in some studies (Malhotra, 
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Dent et al. 2005), but not others (Mankhambo, Kanjala et al. 2002; Mockenhaupt, Ulmen 
et al. 2002). 
Malaria reduces blood flow from the mother to the placenta and from the fetus to 
the placenta from the early second trimester until delivery. Reduced utero- and 
fetoplacental blood flow is a likely mechanism by which malaria leads to intrauterine 
growth restriction. Adequate malaria prevention and control measures should be 
implemented to prevent the adverse effects of malaria during pregnancy. The effects of 
malaria on fetoplacental blood flow are sex-specific, possibly via sex-specific placental 
cytokine responses to malaria parasitemia. Research should attempt to clarify the sex-
specific pathological effects of malaria in pregnancy. 
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Table 4.1 Characteristics of pregnant women, with estimated mean differences and 95% confidence intervals (CI) in uterine artery 
resistance index (UtA RI) and umbilical artery resistance index (UA RI). Democratic Republic of Congo, 2005-2006.  
   UtA RIa    UA RIb   
Characteristic n (%)  Mean difference (95% CI) P  Mean difference (95% CI) P 
           
Maternal age ≥30 64 (36)  0.011 (-0.012, 0.034) 0.35  -0.0015 (-0.019, 0.016) 0.86 
 25-29 57 (32)  Ref. -   Ref. -  
 <25 56 (32)  -0.018 (-0.042, 0.0057) 0.16  0.00050 (-0.018, 0.019) 0.96 
           
Primigravidae Yes 46 (26)  -0.0078 (-0.030, 0.014) 0.48  0.026 (0.010, 0.42) 0.002 
 No 131 (74)  Ref. -   Ref. -  
           
Fetal sex Female 81 (53)  0.024 (0.005, 0.43) 0.01  0.022 (0.008, 0.036) 0.003 
 Male 93 (47)  Ref. -   Ref. -  
           
Low SES Yes 153 (86)  -0.0087 (-0.036, 0.019) 0.53  -0.0011 (-0.022, 0.020) 0.92 
 No 24 (14)  Ref. -   Ref. -  
           
Low education Yes 88 (50)  -0.0086 (-0.028, 0.011) 0.37  -0.019 (-0.033, -0.0050 0.008 
 No 89 (50)  Ref. -   Ref. -  
           
Low MUAC Yes 45 (25)  0.00010 (-0.022, 0.022) 0.99  -0.0027 (-0.019, 0.014) 0.75 
 No 132 (75)  Ref. -   Ref. -  
           
a. The standard deviation for UtA RI is 0.088, without considering repeated measures 
b. The standard deviation for UA RI is 0.090, without considering repeated measures 
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Table 4.2 Perinatal outcomes by high uterine artery resistance index (UtA RI) and umbilical artery resistance index (UA RI) 
(n=163).Democratic Republic of Congo, 2005-2006.  
  High UtA RI    High UA RI   
  Ever  Never    Ever  Never    
Perinatal outcomes  n (%) n (%) RR (95% CI) P  n (%) n (%) RR (95% CI) P 
           
Low birth weight  8/72 
(11) 
8/102 (8) 1.4 (0.6, 3.6) 0.46  10/72 
(14) 
6/102 (6) 2.4 (0.9, 6.2) 0.07 
Small for gestational age  34/72 
(47) 
25/100 
(25) 
1.9 (1.2, 2.9) 0.002  34/72 
(47) 
25/100 
(25) 
1.9 (1.2, 2.9) 0.002 
Preterm (<37 weeks)  5/72 (7) 6/102 (6) 1.2 (0.4, 3.8) 0.77  6/72 (8) 5/102 (5) 1.7 (0.5, 5.4) 0.36 
           
  Mean Mean Difference (95% 
CI) 
P  Mean Mean Difference (95% 
CI) 
P 
Gestational age at delivery 
(days) 
 274 275 -1 (-5, 2) 
 
0.40  274 275 -1 (-3, 4) 
 
0.80 
Birth weight (grams)  2860 3069 -210 (-346, -74) 
 
0.003  2874 3060 -185 (-322, -48) 
 
0.009 
Head circumference (cm)  33.7 34.3 -0.7 (-1.4, 0.02) 
 
0.07  34.0 34.2 -0.2 (-0.9, 0.5) 
 
0.54 
Abdominal circumference 
(cm) 
 27.4 28.2 -0.8 (-1.5, -0.04) 
 
0.04  27.5 28.1 -0.5 (-1.3, 0.2) 
 
0.15 
Crown-rump length (cm)  32.7 33.5 -0.8 (-1.3, -0.2) 
 
0.009  32.9 33.4 -0.5 (-1.1, 0.04) 
 
0.06 
           
RR = risk ratio; CI: confidence interval 
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Figure 4.1 Time plots of mean uterine artery resistance index and umbilical artery 
resistance index against gestational age (in weeks), with population average smoothed 
trend line (in black). (n=177, with 765 visits) (Democratic Republic of Congo, 2005-2006.  
A. Uterine artery resistance index against gestational age. B. Umbilical artery resistance 
index against gestational age. 
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Figure 4.2 Linear mixed effect model estimated population average growth curves for the 
mean uterine artery resistance index by malaria against gestational age (in weeks). 
Democratic Republic of Congo, 2005-2006. A. The unadjusted effect of malaria on 
uterine artery resistance (n=759 visits). B. The adjusted effect of malaria on uterine 
artery resistance by gravidity. Model adjusted for maternal age and low education level; 
product interaction term (malaria * primigravidae) P = 0.038, with 1 df (n=759 visits). The 
standard deviation for UtA RI is 0.088, without considering repeated measures. 
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Figure 4.3 Linear mixed effect model estimated population average growth curves for the 
umbilical artery resistance index by malaria against gestational age (in weeks). 
Democratic Republic of Congo, 2005-2006. A. The unadjusted effect of malaria on 
umbilical artery resistance (n= 760 visits).  B. The adjusted effect of malaria on umbilical 
artery resistance by fetal sex. Model adjusted for gravidity; product interaction term 
(Malaria * fetal sex) P = 0.065, with 1 df (n=755 visits). The standard deviation for UA RI 
is 0.090, without considering repeated measures. 
  
  
CHAPTER 5 - THE EFFECT OF MALARIA IN EARLY PREGNANCY ON 
PLACENTAL BLOOD FLOW AND FETAL GROWTH: A LONGITUDINAL 
ULTRASOUND STUDY FROM THE DEMOCRATIC REPUBLIC OF CONGO 
Abstract 
Objective: The objective of this analysis was to examine the hypothesis that early 
pregnancy malaria parasitemia leads to subsequent changes in uteroplacental blood 
flow and fetal growth. 
Design: Data were analyzed from pregnant women from Democratic Republic of Congo 
who participated in a longitudinal Doppler ultrasound study. 128 women had 548 
antenatal visits after 20 weeks’ gestation that included fetal biometric measures and 
interrogation of uterine and umbilical blood flow. 
Methods: Using linear mixed effects models, we examined the effect of early pregnancy 
malaria (≤20 weeks’ gestation) on subsequent changes (>20 weeks’ gestation) in the 
mean uterine and umbilical artery resistance indices and sonographically estimated fetal 
weight. We used log-binomial models with generalized estimating equations to estimate 
effect of early pregnancy malaria on the risk of subsequent IUGR. 
Results: The effect of early pregnancy malaria on UtA RI varied by maternal nutritional 
status Among nourished women, early pregnancy malaria decreased UtA RI (-0.036; 
95% CI: -0.065, -0.0058), but among undernourished women, early pregnancy malaria 
increased UtA RI (+0.022; 95% CI: -0.031, 0.074). The effect of early pregnancy malaria 
on UA RI varied by gravidity. Among primigravidae, early pregnancy malaria decreased 
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UA RI. Primigravidae with early pregnancy malaria had 3.6 times the risk of subsequent 
IUGR (95% CI: 2.1, 6.2) compared to the referent group of multigravidae with no early 
pregnancy malaria. Early pregnancy malaria was associated with a small increased risk 
of IUGR among multigravidae that was not significant. 
Conclusions: Early pregnancy malaria affects uterine and umbilical artery blood flow, 
indicating alterations in placentation and angiogenesis, respectively. Among 
primigravidae, early pregnancy malaria leads to decreased fetal growth and increased 
risk of IUGR. Our findings support the initiation of malaria prevention and control efforts 
earlier in pregnancy. 
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Introduction 
In malaria endemic areas, the WHO recommends prevention and control 
strategies for malaria in pregnancy, including case management of malaria and anemia; 
insecticide-treated nets; and, at least two doses of intermittent preventive treatment 
(IPTp) in pregnancy with sulfadoxine-pyrimethamine after the awareness of fetal 
movement (WHO 2004) (from approximately 17-19 weeks’ gestation (O'Dowd and 
O'Dowd 1985)).The peak prevalence of malaria in pregnancy occurs from 13 to 20 
weeks’ gestation (Brabin 1983), mostly prior to the first dose of IPTp (WHO 2004).  
During this critical period of early pregnancy, the placenta develops to meet the 
growing metabolic demands of the fetus. Extravillous trophoblasts invade and remodel 
the uterine spiral arteries, increasing uterine artery blood flow to the maternal side of the 
placenta. Concurrently, villous angiogenesis leads to increased umbilical artery blood 
flow to the fetal side of the placenta. 
Doppler ultrasound allows the non-invasive investigation of utero- and 
fetoplacental blood flow and resistance. The assessment of uterine artery blood flow 
reflects the extent of trophoblast invasion of the spiral arteries (Prefumo, Sebire et al. 
2004; Sebire and Sepulveda 2008). Abnormal uterine artery resistance is associated 
with preeclampsia, IUGR and adverse pregnancy outcomes (Trudinger, Giles et al. 
1985). Increased umbilical artery resistance is associated with fetal distress and IUGR 
(Giles, Trudinger et al. 1985; Trudinger, Giles et al. 1985). In addition, fetal biometry 
measurements can be used to estimate fetal weight and to identify IUGR fetuses by 
comparing estimated fetal weights to population growth charts. 
It has been previously hypothesized that malaria in early pregnancy disrupts 
trophoblast invasion (Dorman, Shulman et al. 2002), leading to diminished 
uteroplacental blood flow and, ultimately, intrauterine growth restriction (IUGR). The 
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objective of this analysis was to examine the hypothesis that early pregnancy malaria 
leads to subsequent changes in uterine artery (UtA) and umbilical artery (UA) resistance 
indices (RI). We also examined the effect of early pregnancy malaria on the risk of 
subsequent IUGR. 
Methods 
Study population 
The longitudinal cohort consisted of pregnant women presenting for first 
antenatal care (ANC) at Binza Maternity Hospital in Kinshasa, Democratic Republic of 
Congo (DRC) between May 2005 and May 2006, as previously described (Landis 2007; 
Landis, Lokomba et al. 2009). In brief, 182 pregnant women ≥ 18 years, with non-
hypertensive, non-anomalous singleton pregnancies; and, ultrasound-derived 
gestational age of ≤22 weeks were enrolled and followed until delivery. Enrolled women 
were provided with ITNs and received IPTp with sulfadoxine-pyrimethamine twice during 
pregnancy (between 16-27 and 28-32 weeks’ gestation) regardless of malaria status. All 
women with microscopy positive malaria were treated throughout follow-up.  
Enrolled women provided written informed consent. This study was approved by 
the Institutional Review Boards of the University of North Carolina at Chapel Hill and the 
Kinshasa School of Public Health.  
For the current analysis of early pregnancy malaria exposure, we excluded 5 
HIV-positive participants and 49 participants with no malaria exposure data ≤ 20 weeks’ 
gestation, leaving an analytic sample of 128 women, with 548 antenatal visits after 20 
weeks’ gestation that included fetal biometric measures and interrogation of uterine and 
umbilical blood flow. Excluded participants did not significantly differ from the analytic 
population in age, gravidity, fetal sex, or socioeconomic status (SES), but were more 
84 
 
likely to have a low level of education and to be undernourished (data not shown). 
Participants in the analytical sample were enrolled at a median of 18 weeks’ gestation 
(interquartile range [IQR]: 16, 19) and were followed up for a median of 19 weeks (IQR: 
17, 21). Study participants had a median of 7 follow-up visits (IQR: 6, 8), with 5 
ultrasound scans (IQR: 4, 5) from enrollment to delivery.  
Clinical, Laboratory, and Ultrasound Procedures 
Baseline data were collected in an interview (socio-demographics, medical 
history); medical examination (maternal anthropometrics, blood pressure, pulse, 
temperature); ultrasound examination (estimation of gestational age and fetal weight); 
and laboratory testing (urine protein; hematocrit; malaria thick and thin smears; and, filter 
paper dried blood spot samples of peripheral blood) as previously described (Landis, 
Lokomba et al. 2009). At monthly antenatal care visits women repeated ultrasound, 
medical, and laboratory examinations (including malaria thick and thin smears and filter 
paper dried blood spot samples). Quantitative real-time polymerase chain reaction 
(qPCR) was conducted to detect all Plasmodium species from dried blood spot samples 
and Plasmodium positive samples were speciated as previously described (Taylor, 
Juliano et al. 2010).  
Color pulsed-wave Doppler ultrasound was used to interrogate the flow velocity 
waveforms in the left and right UtAs and the UA using standard techniques. The external 
iliac artery and UtA located medial to it were identified using color flow settings. Flow 
velocity waveforms were obtained from the UtA near the iliac vessel prior to division of 
the UtA into branches. For left and right UtA analyses, Doppler indices were measured 
from the Doppler signal, with qualitative assessment of early diastolic notching. For the 
UA, the flow velocity waveform was obtained from the free flowing portion of the 
umbilical cord and Doppler indices and presence of absent or reversed end-diastolic flow 
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were recorded. All ultrasound measurements were taken by a single, trained 
obstetrician-gynecologist (V.L.) on the GE Logicbook Ultrasound System. 
Variable definitions 
The exposure variable, ‘early pregnancy malaria,’ was a binary, time-
independent measure representing whether a woman was ever qPCR positive for 
peripheral P. falciparum malaria parasitemia ≤20 weeks’ gestation. We utilized qPCR of 
peripheral dried blood spots rather than blood microscopy due to the higher detection 
threshold of microscopy and the potential for poor microscopy sensitivity and specificity 
(Ohrt, Obare et al. 2007). 
Outcome variables for placental blood flow included the continuous, time-
dependent mean of the left and right uterine artery (UtA) resistance index; and, the 
umbilical artery (UA) resistance index (RI) after 20 weeks’ gestation. The RI is defined 
as: (peak systolic velocity – end diastolic velocity) / peak systolic velocity. We selected 
the resistance index for our outcome for several reasons: RI values are constrained 
between 0 and 1; demonstrate the least variance of the Doppler indices under identical 
hemodynamic conditions; are frequently used in clinical settings; and have a truncated 
normal distribution, making the RI amenable to parametric statistical analyses (Maulik 
2005).  
We also examined IUGR after 20 weeks’ gestation. IUGR was a binary, time-
dependent outcome. At each visit, women were classified as having an IUGR episode if, 
at that visit, their fetus was <10th percentile of estimated fetal weight for gestational age 
in completed weeks, using Hadlock’s algorithm to estimate fetal weight (Hadlock, Harrist 
et al. 1991) and the ultrasound-derived, longitudinal, sex-specific Johnsen fetal growth 
standard (Johnsen, Rasmussen et al. 2006). We also examined repeated episodes of 
IUGR. “Repeat IUGR” was a binary, time-dependent outcome defined as IUGR (as 
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previously defined), with ≥ 2 total IUGR episodes during pregnancy. As this analysis was 
focused on IUGR, fetal weight was not considered. 
The continuous time metric, gestational age in weeks, was back-calculated from 
the first ultrasound using Hadlock’s algorithm (Hadlock, Deter et al. 1984). Ultrasound 
estimated gestational age has been shown to provide a better estimate of gestational 
age, even when last menstrual period dates are considered certain (Mongelli, Wilcox et 
al. 1996). 
We hypothesized that the effects of early pregnancy malaria on uteroplacental 
blood flow and IUGR would be modified by primigravidity (vs. multigravidity), female fetal 
sex (vs. male), and baseline maternal mid-upper arm circumference (MUAC) ≤24.3 cm 
(i.e. the lowest quartile of the full study population)(vs. ‘normal’ MUAC). MUAC is a proxy 
for pre-pregnancy weight (Krasovec and Anderson 1991). Potential confounders 
included maternal age, education, fetal sex, and socioeconomic status (SES). ‘Low SES’ 
was defined as a binary composite variable, with unemployed women (or their partners) 
living in a home with few assets (no toilet, no water, no electricity) categorized as ‘low 
SES.’ 
Statistical Analysis 
For linear mixed effect (LME) models, we reported mean differences and plotted 
population average growth curves to describe the unadjusted and adjusted effect of 
early pregnancy malaria on UtA RI and UA RI. To describe the effect of early pregnancy 
malaria on IUGR, we estimated unadjusted and adjusted risk ratios (RRs) and 95% CIs 
using log-binomial regression generalized estimating equation (GEE) regression models 
with an exchangeable working correlation matrix. LME and GEE regression models are 
appropriate for longitudinal analyses as they account for the correlation between 
repeated measures in an individual (Laird and Ware 1982; Liang and Zeger 1986).  
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For multivariable modeling of the effect of early pregnancy malaria on UtA RI and 
UA RI, we began with a fully adjusted LME model with a random intercept. Linearity 
between gestational age and the outcome variables was considering by examining 
polynomial transformations of gestational age using -2 log-likelihood (-2LL) tests for 
nested models using maximum likelihood [ML] estimation (a priori cutoff of p < 0.10). We 
tested the addition of additional random effects using -2LL tests with a mixed chi-square 
distribution (a priori cutoff of p<0.05). In the final UtA RI and UA RI models we included 
random intercepts and slopes for each woman. For log-binomial GEE models, we began 
with a crude model fitted for the early pregnancy malaria exposure variable. Next, we 
constructed simple log-binomial models with early pregnancy malaria, a theorized effect 
measure modifier, and their product interaction term. If the product interaction term was 
significant using the Wald test (a priori cut-off of 0.10), it was considered an effect 
measure modifier and was included in the multivariable model. For multivariable 
modeling, we began with a fully adjusted log-binomial model, including the early 
pregnancy malaria exposure, the significant product interaction terms and potential 
confounders of the association between malaria and IUGR. First, we utilized a backward 
elimination approach to assess effect measure modification. In LME models, -2LL tests 
were used to assess the contribution of the product interaction terms to the model using 
a maximum likelihood (ML) approach; in GEE models, Wald tests were used (a priori 
cutoffs of p < 0.10.)  Potential modifiers that did not modify the association between 
malaria and the outcome were assessed as potential confounders. Covariates were 
considered confounders if the change in the coefficient of the main exposure was 
greater than 10%, within strata of modifiers. Restricted maximum likelihood (REML) was 
used for final LME model estimates, as is common practice (Fitzmaurice 2009). All 
analyses were performed using SAS software (SAS, Cary, NC). 
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Results 
Baseline characteristics of the study population (Table 5.1) 
Among the analytical sample of 128 pregnant women, 30% were ever qPCR 
positive for malaria and 21% had early pregnancy malaria. The mean age of the study 
population was 27.6 years (SD: 5.1; range 18-42). Approximately one-quarter of women 
were primigravidae and one in five women had a low baseline MUAC. More than half of 
women were pregnant with a female fetus. Women with and without early pregnancy 
malaria had approximately balanced gravidity, fetal sex, SES and low baseline MUAC. 
There was a non-significant trend toward greater risk of early pregnancy malaria among 
younger women and women with less education. 
Uteroplacental blood flow and fetal growth (Figure 5.1)  
We plotted individual trajectories of the continuous outcomes, UtA RI and UA RI, 
in order to examine intra- and inter-individual variability over gestational age in weeks. 
There is a slightly negative slope for UtA RI over gestational age (Panel A). UA RI was 
relatively higher in early pregnancy and decreased more rapidly over the course of 
pregnancy (Panel B), due to villous angiogenesis (Abramowicz and Sheiner 2008). Of 
the 44% (55/128) women ever having an IUGR episode after 20 weeks’ gestation, 50% 
had one episode and one-third had two episodes, with 10 women having 3 or more 
episodes. Most IUGR episodes occurred in the late second and early third trimesters. 
Early pregnancy malaria and uterine artery resistance (Figure 5.2) 
There was no crude effect of early pregnancy malaria on UtA RI (mean 
difference: -0.017; 95% CI: -0.045, 0.011)(Panel A). In the adjusted model, the effect of 
early pregnancy malaria on UtA RI varied by maternal nutritional status (Panel B). 
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Compared to the referent group of women with no early pregnancy malaria with normal 
MUAC, the mean difference in UtA RI was -0.032 (95% CI: -0.062, -0.0006) for early 
pregnancy malaria and -0.011 (95% CI: -0.042, 0.019) for low MUAC. The joint mean 
difference in UtA RI for women with early pregnancy malaria and low MUAC was +0.022 
(95% CI: -0.031, 0.076), or approximately one-fourth of a standard deviation (-2LL test 
for product interaction term p = 0.026). In other words, compared to the referent group, 
early pregnancy malaria caused a chronic increase in UtA RI of 4% among 
undernourished women, but caused a decrease in UtA RI of 6% among nourished 
women. Fetal sex and gravidity were not found to modify the association between early 
pregnancy malaria and UtA RI. 
Early pregnancy malaria and umbilical artery resistance (Figure 5.3) 
There was no crude effect of early pregnancy malaria on UA RI (Panel A). In the 
adjusted model, the effect of early pregnancy malaria on UA RI varied over time and by 
gravidity (Panel B). Compared to the referent group of multigravidae with no early 
pregnancy malaria, the mean difference in UA RI for early pregnancy malaria varied 
from 0.038 (95% CI: 0.0065, 0.069) at 21 weeks’ gestation to -0.0087 (95% CI: -0.04, 
0.03) at 39 weeks’ gestation. The mean difference in UA RI was 0.032 (95% CI: 0.012, 
0.052) for primigravidae. The mean difference in UA RI for the joint effect of early 
pregnancy malaria and primigravidity varied from 0.012 (95% CI: -0.030, 0.055) at 21 
weeks’ gestation to -0.032 (95% CI: -0.079, 0.011) at 39 weeks’ gestation. Thus, 
multigravidae with early pregnancy malaria had elevated UA RI that decreased to levels 
similar to unexposed multigravidae during the third trimester. Among primigravidae, early 
pregnancy malaria led to decreased UA RI during the late third trimester, particularly 
compared to primigravidae with no early pregnancy malaria. 
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Early pregnancy malaria and intrauterine growth restriction (Table 5.2) 
In the unadjusted model, early pregnancy malaria was associated with 1.8 times 
the risk of subsequent IUGR during pregnancy (95% CI: 1.1, 2.9). In the adjusted model, 
the effect of early pregnancy malaria was found to vary by gravidity (Wald test for 
product interaction term: p = 0.035). Primigravidae with early pregnancy malaria had 3.6 
times the risk of subsequent IUGR compared to the referent group of multigravidae with 
no early pregnancy malaria (95% CI: 2.1, 6.2). Early pregnancy malaria was associated 
with a small increased risk of IUGR among multigravidae; this finding did not reach 
statistical significance. In the unadjusted model for repeat IUGR, early pregnancy 
malaria was associated with 2.2 times the risk of repeat IUGR episodes. In the adjusted 
model, the risk of repeat IUGR episodes among primigravidae with early pregnancy 
malaria was 5.6 (95% CI: 2.8, 11.3). The increased risk for repeat IUGR with early 
pregnancy malaria likely reflects the better ability of repeated episodes of <10th 
percentile SEFW to capture truly IUGR fetuses than a single episode. 
Discussion 
This is the first study to demonstrate that early pregnancy malaria leads to 
altered placentation and intrauterine growth restriction. These observations have 
important implications for the timing of malaria prevention and control efforts. The effects 
of early pregnancy malaria could be seen on both uterine and umbilical artery blood flow, 
indicating altered placentation and villous angiogenesis, respectively. Primigravidae with 
early pregnancy malaria had greater than three times the risk of subsequent IUGR and 
greater than five times the risk of repeat IUGR episodes compared to multigravidae with 
no early pregnancy malaria. The effects of early pregnancy malaria on fetal growth were 
less pronounced among multigravidae, suggesting that the effects of early pregnancy 
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malaria are worse for primigravidae than multigravidae, as described at term (Desai, ter 
Kuile et al. 2007).  
We found early pregnancy malaria increased UtA RI among women with low 
MUAC, but decreased UtA RI among women with normal MUAC. These differential 
effects of early pregnancy malaria on UtA RI between women with low and normal 
MUAC suggest important interactions between malaria and nutritional status on 
placental development (Prefumo, Sebire et al. 2004; Sebire and Sepulveda 2008). The 
effects of malaria on fetal growth have previously been shown to vary by nutritional 
status (Landis, Lokomba et al. 2009), but the joint effects of malaria and nutritional 
status during pregnancy on the fetus are not well understood.  
Extravillous trophoblast invasion is highly regulated and is critical to establishing 
physiologic uteroplacental blood flow. Malaria in the placenta could dysregulate 
trophoblast invasion via relative placental hypoxia (Genbacev, Zhou et al. 1997; Arbeille, 
Carles et al. 1998); increases in inflammatory cells and mediators (such as TNFα) (Yui, 
Garcia-Lloret et al. 1994; Ordi, Menendez et al. 2001; Renaud, Postovit et al. 2005); 
functional folate deficiency (Williams, Bulmer et al. ; Brabin, Alexander Fletcher et al. 
2003); and/or, increased complement activation (Conroy, McDonald et al. ; Girardi, Bulla 
et al. 2006).  
We found increased uterine artery resistance with early pregnancy malaria 
among undernourished women. This finding indicates that placental malaria may be 
associated with diseases of trophoblast hypo-invasion, such as preeclampsia 
(Muehlenbachs, Mutabingwa et al. 2006). We also found evidence consistent with 
increased trophoblast invasion among nourished women with early pregnancy malaria. 
Placental bed biopsies are necessary to determine if the effects of early pregnancy 
malaria on trophoblast invasion are physiological or pathological, as in retained placenta 
or placenta accreta (Hung, Shau et al. 1999). Our findings demonstrate that malaria 
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infection during early pregnancy affects placentation, likely via dysregulation of 
extravillous trophoblast invasion, and may contribute to diseases of both trophoblast 
hypo- and hyper-invasion.  
Among primigravidae, early pregnancy malaria led to decreased umbilical artery 
resistance, indicating increased angiogenesis in the villous tree of the placenta 
(Abramowicz and Sheiner 2008). Adaptive villous branching and capillarization occur in 
hypoxic placental environments, including term preeclampsia (Kingdom and Kaufmann 
1997), high altitude (Jackson, Mayhew et al.), smoking (Pfarrer, Macara et al. 1999), and 
anemia (Kadyrov and Kosanke 1998). Branching angiogenesis is associated with 
increased VEGF expression (Cao, Linden et al. 1996), previously shown to be 
associated with placental malaria and maternal hypertension (Muehlenbachs, 
Mutabingwa et al. 2006). Increased villous angiogenesis may explain the previously 
reported high placental to fetal weight ratio among primigravidae with placental malaria 
(Brabin, Romagosa et al. 2004), potentially linking malaria in early pregnancy to future 
cardiovascular disease (Barker, Bull et al. 1990). 
Primigravidae with early pregnancy malaria had an increased risk of IUGR, 
compared to multigravidae with no early pregnancy malaria. Our findings support limited, 
but growing, evidence that malaria infection adversely affects birth weight (Kalilani, 
Mofolo et al. ; Taha, Gray et al. 1993; Cottrell, Mary et al. 2007; Huynh BT 2011). We 
found that the adverse effect of early pregnancy malaria on fetal growth in primigravidae 
occurred despite a blood flow profile consistent with normal placentation and increased 
angiogenesis. This suggests that the effects of early pregnancy malaria on fetal growth 
occur at the time of infection and are mediated via other mechanistic pathways, such as 
inflammatory cells and cytokines (Fried, Muga et al. 1998), anemia (Menendez, Ordi et 
al. 2000), or acute changes in blood flow during active parasitemia (Dorman, Shulman et 
al. 2002).  
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The prevalence of malaria parasitemia peaks in early pregnancy (Brabin 1983) 
and malaria prevention and control measures are infrequently initiated (WHO 2004) 
during this critical period in placental development. Our findings support the initiation of 
malaria prevention and control efforts earlier in pregnancy. The risks and benefits of anti-
malaria drug treatment in early pregnancy must be carefully investigated. 
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Table 5.1 Characteristics of 128 mothers at baseline by early pregnancy malaria status. 
Kinshasa, Democratic Republic of Congo, 2005-2006.  
Characteristic  Total 
(n=128) 
 Early pregnancy 
malaria (n=27) 
 No early 
pregnancy malaria 
(n=101) 
 Pa 
  N(%)  N(%)  N(%)   
Maternal age         
 ≥30  48 (38)  6 (22)  42 (42)  0.13 
 25-29  40 (31)  9 (33)  31 (31)   
 <25  40 (31)  12 (44)  28 (28)   
Gravidity         
 Primigravidae  34 (27)  6 (18)  28 (82)  0.56 
 Multigravidae  94 (73)  21 (22)  73 (78)   
Fetal sex         
 Female  70 (55)  17 (24)  53 (76)  0.36 
 Male  57 (45)  10 (18)  47 (83)   
Low SES         
 Yes  109 (85)  23 (21)  86 (79)  0.99 
 No  19 (15)  4 (21)  15 (79)   
Low education         
 Yes  55 (43)  16 (29)  39 (71)  0.054 
 No  74 (57)  11 (15)  62 (85)   
Baseline MUAC 
<24.3 
        
 Yes  28 (22)  6 (21)  22 (79)  0.96 
 No  100 (78)  21 (21)  79 (79)   
          
SES, socioeconomic status; MUAC, mid-upper arm circumference 
a. p-values are for the comparison of women with early pregnancy malaria to women with no 
early pregnancy malaria. 
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Table 5.2 GEE log-binomial model estimated unadjusted and adjusted risk ratios (RR) 
for the effect of early pregnancy malaria on intrauterine growth restriction (IUGR) and 
repeat IUGR. Adjusted models stratified by gravidity. (n=544). Kinshasa, Democratic 
Republic of Congo, 2005-2006. 
  Early pregnancy malaria No early pregnancy malaria 
  RR (95% CI) RR (95% CI) 
IUGR      
Unadjusted  1.8 (1.1, 2.9) 1.0 Ref. 
Adjustedab      
 Primigravidae  3.6 (2.1, 6.2) 1.1 (0.6, 1.9) 
 Multigravidae  1.4 (0.8, 2.5) 1.0 Ref. 
       
Repeat IUGR      
Unadjusted  2.2 (1.1, 4.2) 1.0 Ref. 
Adjustedcd      
 Primigravidae  5.6 (2.8, 11.3) 1.2 (0.5, 3.0) 
 Multigravidae  1.4 (0.6, 3.6) 1.0 Ref. 
       
GEE = Generalized estimating equation 
a. Adjusted for fetal sex and low baseline MUAC 
b. Interaction term (early pregnancy malaria*primigravidae) p = 0.035 
c. Adjusted for fetal sex and low baseline MUAC 
d. Interaction term (early pregnancy malaria*primigravidae) p = 0.06
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Figure 5.1 Time plot of mean uterine artery resistance index and umbilical artery 
resistance index against gestational age (in weeks), with population average smoothed 
trend line (in black). (n=128, with 544 visits) Kinshasa, Democratic Republic of Congo, 
2005-2006.  A. Uterine artery resistance index against gestational age. B. Umbilical 
artery resistance index against gestational age. 
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Figure 5.2 Estimated population average growth curves for the mean uterine artery 
resistance index (UtA RI) by early pregnancy malaria against gestational age (in weeks). 
Kinshasa, Democratic Republic of Congo, 2005-2006. A. The unadjusted effect of early 
pregnancy malaria on UtA RI (n=547 visits). B. The adjusted effect of early pregnancy 
malaria on UtA RI by maternal mid-upper arm circumference (MUAC). Model adjusted 
for gravidity and fetal sex; product interaction term (early pregnancy malaria * low 
MUAC) -2LL test p = 0.026, with 1 df (n=544 visits). The overall standard deviation for 
UtA RI was 0.089.  
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Figure 5.3 Estimated population average growth curves for the umbilical artery 
resistance index (UA RI) by early pregnancy malaria against gestational age (in weeks). 
Kinshasa, Democratic Republic of Congo, 2005-2006. A. The unadjusted effect of early 
pregnancy malaria on UA RI (n= 547 visits).  B. The adjusted effect of early pregnancy 
malaria on UA RI by gravidity. UA RI model adjusted for fetal sex and low education; 
interaction terms: (early pregnancy malaria * gestational age in weeks) -2LL test p = 
0.025; (early pregnancy malaria * primigravidae) -2LL test p = 0.025, with 1 df (n=540 
visits). The overall standard deviation for UA RI was 0.089. 
 
 CHAPTER 6 - DISCUSSION 
Overview 
Nearly a century after the first reports linking malaria during pregnancy to 
adverse pregnancy outcomes (Clark 1915), malaria in pregnancy remains a significant 
public health problem in much of the world. Sub-Saharan Africa carries the bulk of the 
burden of malaria in pregnancy, with 30 million pregnancies and 21 million births 
occurring annually in areas with stable Plasmodium falciparum transmission (WHO 
2003; Dellicour, Tatem et al. 2010). 
In order to prevent the adverse outcomes of malaria during pregnancy in 
endemic settings, the World Health Organization recommends prevention and control 
strategies, including case management of malaria and anemia; ITNs; and, at least two 
doses of IPTp with sulfadoxine-pyrimethamine  after the awareness of fetal movement 
(WHO 2004). These interventions have been shown to reduce the burden of disease 
and improve pregnancy outcomes in endemic areas (Gamble, Ekwaru et al. 2007; ter 
Kuile, van Eijk et al. 2007) 
Unfortunately, despite high uptake of antenatal care in sub-Saharan Africa, IPTp 
and ITN coverage remain unacceptably low. A recent review found that while nearly all 
countries in sub-Saharan Africa had policies in place regarding ITNs and IPTp for 
pregnant women, coverage with ITNs is fewer than one in five pregnant women and 
coverage for a single dose of IPTp is one in four women (van Eijk, Hill et al.). Although 
progress has been made in a handful of countries, the Roll Back Malaria Partnership 
goals for 2010 of 100% coverage of IPTp and at least 80% coverage with ITNs in at-risk 
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areas were not met. To further complicate the issue of control and prevention of malaria 
in pregnancy, IPTp in its current manifestation is threatened by increasing resistance of 
Plasmodium falciparum malaria to SP (Harrington, Mutabingwa et al. ; ter Kuile, van Eijk 
et al. 2007; Mockenhaupt, Bedu-Addo et al. 2008).  
Clearly, there is much work that needs to be done to reduce the burden of 
malaria in pregnancy. Studies of pathological processes during pregnancy resulting from 
malaria provide information that can be used to inform the type and timing of public 
health interventions. In this dissertation, we explored the effect of malaria on two in utero 
processes: utero- and fetoplacental blood flow and fetal growth. The goal of our work 
was to better understand the effect of malaria on pathological changes in pregnancy that 
lead to adverse pregnancy outcomes, in the hope of informing public health practice. 
Summary of findings 
For the first specific aim, our longitudinal analyses focused on the effect of 
concurrent malaria parasitemia on utero- and fetoplacental blood flow. The few previous 
studies investigating this association have indicated that concurrent malaria is 
associated with abnormal uterine artery (Arbeille, Carles et al. 1998; Dorman, Shulman 
et al. 2002) and umbilical artery blood flow (Arbeille, Carles et al. 1998). Our study 
confirmed previous findings that malaria parasitemia leads to increased uterine artery 
resistance among primigravidae (Dorman, Shulman et al. 2002); we did not find 
increased uterine artery resistance among multigravidae with malaria. The variation we 
observed in the effect of malaria on uterine artery blood flow by gravidity is consistent 
with data supporting worse pregnancy outcomes among primigravidae with malaria 
(Desai, ter Kuile et al. 2007). We also investigated the effect of concurrent malaria on 
umbilical artery blood flow. To our knowledge, our results are the first to identify that fetal 
sex modifies the pathological effects of malaria in pregnancy, as malaria significantly 
 101 
 
increased umbilical artery resistance among women pregnant with female fetuses only. 
This finding points to a sex-specific response to malaria parasitemia in pregnancy, 
perhaps due to mechanisms such as sex-specific differences in placental cytokine 
expression, macrophage responses, growth factors, and/or responses to stress 
hormones such as cortisol, as found in asthma (Clifton 2010). Our research also 
confirmed the importance of utero- and fetoplacental blood flow to optimal fetal growth; 
as expected, high uterine and umbilical artery resistance were associated with 
decreases in fetal growth. 
In our second specific aim, we focused on the effect of early pregnancy malaria 
(≤21 weeks’ gestation) on changes in utero- and fetoplacental blood flow, as well as on 
fetal growth. The effect of early pregnancy malaria on uterine artery blood flow varied by 
nutritional status, with undernourished women having increased UtA RI with early 
pregnancy malaria and relatively nourished women having decreased UtA RI with early 
pregnancy malaria. As uterine artery resistance is reflective of the degree of extravillous 
trophoblast invasion of the spiral arteries, our results indicate that early pregnancy 
malaria affects placentation and that this relationship is modified by maternal nutritional 
status. We also examined the effect of early pregnancy malaria on umbilical artery 
resistance. We found that early pregnancy malaria led to decreased umbilical artery 
resistance among primigravidae, reflecting increased villous angiogenesis due to relative 
hypoxia in the placental environment with malaria infection. Finally, we found that early 
pregnancy malaria led to decreased fetal weight and increased risk of IUGR. 
Primigravidae with early pregnancy malaria had greater than three times the risk of 
IUGR compared to multigravidae with no early pregnancy malaria. There was a small, 
non-significant risk of IUGR among multigravidae with early pregnancy malaria. Our 
findings provide the first evidence that early pregnancy malaria affects placentation and 
fetal growth. 
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Together these analyses have contributed to the understanding of the 
pathological effects of malaria in pregnancy on utero- and fetoplacental blood flow and 
fetal growth. Our findings point to two distinct effects of malaria in pregnancy on utero- 
and fetoplacental blood flow: the acute effects of concurrent parasitemia and the effects 
of early pregnancy malaria on placental development. Our results indicate that the timing 
of malaria during pregnancy is important, with early pregnancy malaria infection leading 
to changes in placentation, villous angiogenesis, and fetal growth.  
Public health significance 
Our findings regarding the effects of malaria on utero- and fetoplacental blood 
flow occurred in the context of monthly antenatal care and extensive malaria prevention 
and control measures during pregnancy, as defined by the WHO, including high levels of 
ITN use, two doses of IPTp with SP, and case management of malaria infection and 
anemia. Yet, we found that both malaria parasitemia early in pregnancy and acute 
malaria parasitemia affected feto- and uteroplacental blood flow. Further, there was an 
increased risk of IUGR among primigravidae with early pregnancy malaria. 
Changes in feto- and uteroplacental blood flow are thought to be a mechanism 
by which malaria during pregnancy causes fetal growth restriction. Our study provides 
the first longitudinal evidence that acute malaria parasitemia decreases uterine artery 
blood flow in primigravidae and umbilical artery blood flow among women with a female 
fetus. Our findings emphasize the public health importance of clinical management of 
malaria during pregnancy to prevent the acute effects of malaria on utero- and 
fetoplacental blood flow. Uterine artery blood flow provides oxygen and nutrients to the 
placenta in order to meet the metabolic demands of the fetus, while umbilical artery 
blood flow from the fetus to the placenta allows for the exchange of oxygen and nutrients 
to the fetus. Increased uterine artery and umbilical artery resistance has been shown to 
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lead to restricted fetal growth in animal models and in human studies, as well as in the 
current analysis. 
Considering current recommendations by the WHO regarding the timing of IPTp 
during pregnancy (frequently after 20 weeks’ gestation); existing knowledge of the peak 
prevalence of parasitemia (prior to 20 weeks’ gestation); and timing of the process of 
placentation, we explored the effects of early pregnancy malaria infection on utero- and 
fetoplacental blood flow and fetal growth. A handful of previous studies have shown an 
adverse effect of early pregnancy malaria on birth weight (Kalilani, Mofolo et al. ; Taha, 
Gray et al. 1993; Cottrell, Mary et al. 2007; Huynh BT 2011). Given our findings that 
early pregnancy malaria alters placentation and leads to subsequent IUGR, this study 
provides strong evidence for the initiation of interventions for malaria during pregnancy 
prior to 20 weeks’ gestation. Early pregnancy malaria infection could be found to have 
huge, unexpected public health implications should it be found to be involved in fetal 
programming and future metabolic and cardiovascular disease (Barker, Bull et al. 1990; 
Barker 2006). 
The optimal type and timing of prevention and control efforts will need to be 
explored in intervention trials. The use of chemoprophylaxis for malaria infection in the 
first trimester is riddled with difficulties due to the potential teratogenic effects of anti-
malarials. SP has a good safely profile after the first trimester. However, with increasing 
SP resistance and little data regarding other anti-malarials early in pregnancy, there is 
much to be done.  It will be necessary to weigh the risks and benefits of early 
interventions to the pregnant woman and her fetus. As maternal blood begins to perfuse 
the intervillous spaces of the placenta at approximately 12 weeks’ gestation, potentially 
allowing for parasite sequestration in the placenta, it is possible that interventions, 
particularly ITNs, for malaria in pregnancy would need to begin as early as 12 weeks’ 
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gestation in order to prevent the effects of malaria in pregnancy on placentation and fetal 
growth.  
Our findings also highlight the importance of the methods used to detect malaria 
during pregnancy to studies of pathogenesis and in the management of patients. As we 
previously reported, in the Project ECHO cohort, peripheral blood smear microscopy had 
68% sensitivity and 91% specificity for the identification of peripheral malaria compared 
to qPCR (Taylor, Juliano et al. 2010). PCR of peripheral blood has been shown to have 
nearly 100% sensitivity with placental blood smear as the referent; however, specificity is 
lower (75%) (Mockenhaupt, Ulmen et al. 2002). The “false positives” found in the 
comparison of PCR of peripheral blood to placental blood smear microscopy may 
actually be due to: 1) low sensitivity of placental blood smear microscopy (estimated to 
be 76-78% when compared to the gold standard referent of placental histology) 
(Rogerson, Mkundika et al. 2003); peripheral parasitemia in the absence of placental 
infection; and/or remnant DNA in the peripheral blood from resolved placental infection. 
To date, PCR of peripheral blood at delivery and the gold standard of placental histology 
have not been compared. While qPCR is highly sensitive and specific, the clinical 
relevance of submicroscopic infections is under debate (Mankhambo, Kanjala et al. 
2002; Malhotra, Dent et al. 2005; Mockenhaupt, Bedu-Addo et al. 2006). 
Future research directions 
The study of malaria in pregnancy combines challenges from infectious disease 
epidemiology and perinatal epidemiology. The identification of placental malaria in 
antenatal studies of malaria in pregnancy is problematic. While studies of malaria in 
pregnancy are most important in sub-Saharan Africa and Asia, most commonly used 
tools for perinatal epidemiology have been developed in the United States and Europe. 
These tools include algorithms for the estimation of gestational age, and nomograms for 
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the clinical classification of placental blood flow and fetal growth as normal or abnormal. 
In addition to several research directions that could improve the methods available for 
the study of malaria in pregnancy, several interesting study questions regarding potential 
pathological mechanisms emerged from our analyses of malaria in pregnancy on utero- 
and fetoplacental blood flow and fetal growth. 
Improving exposure definitions for malaria during pregnancy: 
A better understanding is needed of the diagnostic test characteristics used in 
the identification of placental malaria, including placental blood smear, rapid tests, 
immunohistochemistry, qPCR and nested-PCR, among others. Our understanding of the 
diagnostic test characteristics for placental malaria can be biased by the utilization of an 
imperfect gold standard. However, there are statistical tools, including latent class 
analysis (LCA) and Bayesian techniques, which can be used to compare the test 
characteristics in the absence of a gold standard test. Peripheral measures at term can 
be compared to placental measures to find improved antenatal measures of placental 
malaria. As diagnostic tools become more sensitive, their clinical relevance may 
decrease; thus, the predictive value of different diagnostic methods for relevant birth 
outcomes should also be explored. It is worth noting that higher levels of sensitivity may 
remain relevant for studies of pathogenesis. Improving our understanding of diagnostic 
methods for placental malaria infection and antenatal peripheral malaria, as well as their 
correlation would be an important contribution to the field of malaria in pregnancy. 
Developing longitudinally-derived nomograms for utero- and fetoplacental blood flow 
Similarly to the estimated fetal weight nomogram developed from Project ECHO 
data (Landis, Ananth et al. 2009), Doppler ultrasound data from Project ECHO can be 
used to develop longitudinally-derived nomograms for Doppler resistance indices. To our 
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knowledge, these would be the first longitudinal nomograms for uterine and umbilical 
artery resistance in sub-Saharan Africa. Doppler ultrasound nomograms could be an 
important tool in antenatal studies of placental blood flow and fetal growth, as well as an 
important clinical tool in sub-Saharan Africa. 
Exploring the modifying effects of fetal sex on the malaria and pregnancy outcome 
relationship 
As fetal sex is commonly noted in studies, there is a great potential for secondary 
analyses on the modifying effects of fetal sex on the relationship between malaria, the 
placenta, the fetus, and pregnancy outcomes. There may be important sex-specific 
differences in placental cytokine expression, macrophage responses, growth factors, 
and/or responses to stress hormones. Should it be found to be an important modifier of 
the relationship between malaria and pregnancy outcomes, fetal sex will need to be 
considered in future research questions and study design. 
Sex-specific responses to malaria can also be viewed through the lens of 
evolutionary biology. Sub-Saharan Africa has the highest male to female ratios in the 
world (Nigeria>1.050), as well as the lowest (<1.00 in DR Congo and Zambia). The sex 
ratio at birth is highest in younger pregnancies in sub-Saharan Africa, as well as among 
women with lower parity. Female fetuses have been found to have higher prevalence of 
placental infection at delivery than male fetuses. It would be interesting to investigate the 
hypothesis that malaria in pregnancy plays a role in sex-selection (likely via early 
spontaneous abortion) in sub-Saharan Africa. 
Early pregnancy malaria and placentation 
Due to our findings regarding the effects of early pregnancy malaria (<20 weeks’ 
gestation) on placentation and angiogenesis, we hypothesized that early pregnancy 
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malaria could have an effect on another aspect of placentation: placental location. 
Preliminary analyses suggest that malaria in early pregnancy is associated with an 
increased risk of low-lying placenta and decreased risk of a posterior site of placental 
attachment. Placental location is associated with adverse pregnancy outcomes, 
including preterm, IUGR, previa, and placenta accreta. It may be found that placental 
location explains some of the effects of early pregnancy malaria on changes in utero- 
and fetoplacental blood flow and pregnancy outcomes. Similarly, studies exploring the 
effects of early pregnancy malaria on the depth of trophoblast invasion would better 
elucidate whether early pregnancy malaria leads to alterations in placentation that are 
pathological or within physiologic norms.  
Early pregnancy malaria and chronic disease 
Sub-Saharan Africa is said to bear the double burden of infectious and chronic 
disease. In Aim 2, we found that early pregnancy malaria altered placentation and villous 
angiogenesis. Increased villous angiogenesis may explain the relatively high placental to 
fetal weight ratio among primigravidae with placental malaria. High placental to fetal 
weight ratios are predictive of future cardiovascular disease (Barker, Bull et al. 1990). 
Evidence increasingly supports a relationship between fetal “programming” in the 
placenta and health in later years. It would be interesting to explore the relationships 
between malaria exposure (and its timing) and patterns of non-communicable chronic 
disease. 
Intervention for malaria early in pregnancy 
Future studies should further explore the impact of prevention and control measures 
earlier in pregnancy. The utilization of ITNs and chemoprophylaxis for malaria in early 
pregnancy may be protective for pregnancy outcomes. 
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Examining the effect of malaria during pregnancy on a more specific definition of 
IUGR: 
In utero small for gestational age (SGA) is the most commonly used proxy measure for 
IUGR; however, not all SGA fetuses are IUGR and not all IUGR fetuses are SGA. In 
addition to EFW, there are other fetal biometric manifestations of SGA useful for the 
identification of IUGR, such as abdominal circumference and the HC/AC ratio. 
Regardless of the measure used, estimates of fetal size alone have limited ability to 
distinguish the at-risk, pathologically growth restricted fetus from the healthy, but 
constitutionally small fetus. Currently, the combination of a small fetal abdominal 
circumference or EFW with increased umbilical artery resistance is considered most 
specific diagnosis of placenta-based IUGR, and best identifies small fetuses at risk of 
adverse outcomes (Baschat and Weiner 2000; Ott 2002). It would be useful to 
investigate the relationship between malaria and these, more specific, definitions of 
IUGR. Particularly, as a more specific definition of IUGR would be expected to better 
predict adverse birth outcomes. 
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Appendix 1: Sensitivity Analyses for Aim 1. 
We conducted simple sensitivity analyses for the effect of concurrent malaria on 
UtA RI and UA RI by examining the effect of changing the choice of our time metric and 
our outcome definition on our final model estimates. 
There are two primary methods to estimating in utero gestational age (GA): 1) 
the first day of the last menstrual period (LMP); and, 2) ultrasound dating via fetal 
biometry parameters. While straightforward and inexpensive, the validity of LMP is 
decreased by the uncertain recall of LMP dates; digit preference; and, biologic variation 
in the timing of ovulation, the timing of fertilization, and non-menstrual bleeding (Lynch 
and Zhang 2007). Ultrasound dating has been shown to provide a superior estimate of 
gestational age (Savitz and Terry 2002), even when LMP dates are considered certain 
(Mongelli, Wilcox et al. 1996). The main limitation of ultrasound estimation of gestational 
age is that estimates of gestational age will be biased if the fetus is either large (upward 
or older) or small (downward or younger). 
We examined the difference between last menstrual period (LMP) estimated 
gestational age (GA) and ultrasound (US) estimated GA among the 150 women who 
reported LMP dates. The median LMP estimated GA at enrollment was 19.0 weeks, 
while the median US estimated GA was 19.7 weeks. Compared to LMP estimates, US 
GA was less variable (standard deviation of 2.8 vs 3.3 weeks’ gestation). We examined 
the frequency distribution of the difference between LMP GA and US GA at enrollment 
(Figure A2.1). Positive values indicate that UA GA estimates are younger, while negative 
values indicate that UA GA estimates are older compared to ultrasound based 
estimates. The mean difference between LMP and US estimates of gestational age was 
-0.16 weeks (or -1.2 days), with a standard deviation of 2 weeks. The mean difference 
ranged from -5.6 weeks (-39 days) to 8.3 weeks (58 days). There was a trend toward 
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positive mean differences among all covariates that might be risk factors for a smaller 
fetus at enrollment, although none of the mean differences were significant (Table A1.1). 
This finding indicates that ultrasound estimated gestational age may have 
underestimated the gestational age of older and younger women (vs 25 to 29 year olds); 
women with a female fetus (vs male); and primigravidae (vs multigravidae). 
Finally, we conducted a simple sensitivity analysis to determine how robust our 
model estimates for the effect of malaria on UtA RI (Figure A1.2) and UA RI (Figure 
A1.3) were to changes in our definition of gestational age. The estimated fixed effects 
from the final models using ultrasound estimated gestational age are shown in both 
tables (M). For both UtA RI and UA RI outcomes, final model estimates were robust to 
use of LMP estimated gestational age (S1) and certain dates (S2). Our UtA RI model 
was robust to the use of the highest value from the left and right uterine arteries, rather 
than using the mean value (Figure A1.2; S3). Our models are robust to the choice of 
time metric and outcome definitions. We conclude that while ultrasound estimated 
gestational age may have introduced a small bias to our models, increased sample size 
and precision makes use of ultrasound estimated gestational age a better choice for our 
models. Further, mean UtA RI estimates were more precise than high UtA RI estimates. 
The increased precision attained using the time metric and outcome definition from our 
final selected models (M) makes our chosen definitions preferable to the alternates. 
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Figure A1.1 Frequency distribution of the difference between last menstrual period and 
ultrasound estimated gestational age at baseline in days. (n=150) Democratic Republic 
of Congo, 2005-2006. 
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1
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Table A1.1 Mean difference in LMP and ultrasound estimates of gestational age at enrollment by selected covariates at baseline. 
(n=150) Democratic Republic of Congo, 2005-2006. 
    LMP – ultrasound estimated gestational age in weeks 
Characteristic  N (%)  Mean difference (95% CI) P 
        
Malaria at enrollment Yes  26 (17.3)  0.36 (-0.48, 1.20) 0.40 
 No  124 (82.7)  Ref. -  
Maternal age ≥30  55 (36.7)  0.52 (-0.22, 1.26) 0.17 
 25-29  54 (36.0)  Ref. -  
 <25  54 (36.0)  0.50 (-0.30, 1.30) 0.22 
Gravidity Primigravidae  41 (27.3)  0.35 (-0.36, 1.10) 0.34 
 Multigravidae  109 (72.7)  Ref. -  
Fetal sex Female  82 (55.0)  0.44 (-0.18, 1.07) 0.16 
 Male  67 (45.0)  Ref. -  
Low education Yes  70 (46.7)  -0.26 (-0.90, 0.37) 0.42 
 No  80 (53.3)  Ref. -  
Low baseline MUAC Yes  35 (23.3)  0.10 (-0.64, 0.85) 0.79 
 No  115 (76.7)  Ref. -  
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Figure A1.2 Sensitivity analyses for effect of concurrent malaria on uterine artery 
resistance index (UtA RI). M: main analysis. S1: LMP estimated gestational age (n = 
150, visits = 641). S2: restricted to women with certain gestational age only (n=115, 
visits = 489). S3: use of highest UtA RI value. 
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Figure A1.3 Sensitivity analyses for effect of concurrent malaria on umbilical artery 
resistance index (UA RI).M: main analysis. S1: LMP estimated gestational age (n=149, 
visits = 637). S2: restricted to women with certain gestational age only (n=115, visits = 
489). 
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Appendix 2: Sensitivity Analyses for Aim 2. 
We also conducted a simple sensitivity analysis to determine how robust our 
model estimates for the effect of early pregnancy malaria on UA RI (Figure A2.1) and 
UtA RI (Figure A2.2) were to changes in model definitions. The estimated fixed effects 
from the final models using ultrasound estimated gestational age are shown in both 
figures (M). For UA RI outcomes, final model estimates were robust to use of LMP 
estimated gestational age and certain dates (Figure A2.1, Panels B & C). Our UtA RI 
model was not robust to the use of the highest value from the left and right uterine 
arteries, rather than using the mean value (Figure A2.2; S3), but was robust to use of a 
more stringent definition of our modifying variable. The IUGR models were not robust to 
the use of LMP dates. We again conclude that while ultrasound estimated gestational 
age may have introduced a small bias to our models, increased sample size and 
precision makes use of ultrasound estimated gestational age a better choice for our 
models. The increased precision attained using the time metric from our final selected 
models (M) makes our chosen definitions preferable to the alternates. 
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Figure A2.1 Sensitivity analysis examining the effect of alterations in the definition of the time metric for umbilical artery resistance 
models. Linear mixed effect model estimated population average growth curves for the effect of early pregnancy malaria on umbilical 
artery resistance by gravidity against gestational age (in weeks). All models adjusted for fetal sex and low education. A. Using 
ultrasound estimated gestational age (M – final model). B. Last menstrual period estimated gestational age C. Certain gestational 
age (i.e. LMP within ±14 days of the ultrasound derived date).  
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Figure A2.2 Sensitivity analyses for effect of early pregnancy malaria on uterine artery 
resistance index (UtA RI). M: main analysis. S1: LMP estimated gestational age (n = 
109, visits = 463). S2: restricted to women with certain gestational age only (n=81, visits 
= 361). S3: use of highest UtA RI value. S4: Modifying variable defined as baseline 
MUAC <23 cm. 
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Figure A2.3. Sensitivity analyses for effect of early pregnancy malaria on IUGR. M: 
main analysis. S1: LMP estimated gestational age used to derive EFW (n = 109, 
visits = 463). S2: Hadlock fetal weight standard. S3: Gallivan fetal weight standard. 
 
 1
1
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Table A2.1 Comparison of select fetal weight standards for the identification of IUGR. Democratic Republic of Congo, 2005-2006. 
       Number of measurements 
(%) identified as IUGR 
Nomogram N Country Gestational 
age 
EFW 
algorithm 
used 
Longitudinal Sex-
specific 
Male Female Total 
          
(Johnsen, 
Rasmussen et 
al. 2006) 
643 women; 
1799 
examinations 
Norway Certain LMP 
(Ultrasound 
dating ±14 
days) 
 
(Combs, 
Jaekle et 
al. 1993) 
Y Y 50/265 
(19%) 
46/321 
(14%) 
96/586 
(16%) 
(Hadlock, 
Harrist et al. 
1991) 
 
361 women; 
361 visits 
United 
States 
Certain LMP 
(not defined) 
(Hadlock, 
Harrist et 
al. 1985) 
N N 23/293 
(8%) 
48/357 
(13%) 
71/650 
(11%) 
Gallivan 
(Gallivan, 
Robson et al. 
1993) 
67 women; 434 
scans 
England LMP (BPD and 
FL <7 days 
discrepant) 
(Hadlock, 
Harrist et 
al. 1985) 
Y N 46/264 
(17%) 
85/320 
(26%) 
131/584 
(22%) 
          
LMP = last menstrual period; Note: All populations were healthy women who had received ANC at a clinic or hospital.
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